最新主要文献でみる　脳神経外科学レビュー　2025-’26

I章 脳腫瘍

P.2 掲載の参考文献

1) Sahm F, Brandner S, Bertero L et al:Molecular diagnostic tools for the World Health Organization (WHO) 2021 classification of gliomas, glioneuronal and neuronal tumors;an EANO guideline. Neuro Oncol 25:1731-1749, 2023

 

P.3 掲載の参考文献

2) Buckland ME, Sarkar C, Santosh V et al:Announcing the Asian Oceanian Society of Neuropathology guidelines for Adapting Diagnostic Approaches for Practical Taxonomy in Resource-Restrained Regions (AOSNP-ADAPTR). Brain Pathol 34:e13201, 2024

 

3) Torp SH, Solheim O, Skjulsvik AJ:The WHO 2021 Classification of Central Nervous System tumours:a practical update on what neurosurgeons need to know-a minireview. Acta Neurochir (Wien) 164:2453-2464, 2022

 

4) 小森隆司:WHO脳腫瘍分類2021第5版-主な変更点. Brain Nerve 74:803-809, 2022

 

P.4 掲載の参考文献

5) Jamshidi P, Brat DJ:The 2021 WHO classification of central nervous system tumors:what neurologists need to know. Curr Opin Neurol 35:764-771, 2022

 

6) McNamara C, Mankad K, Thust S et al:2021 WHO classification of tumours of the central nervous system:a review for the neuroradiologist. Neuroradiology 64:1919-1950, 2022

 

7) Joyner DA, Garrett J, Batchala PP et al:MRI features predict tumor grade in isocitrate dehydrogenase (IDH) -mutant astrocytoma and oligodendroglioma. Neuroradiology 65:121-129, 2023

 

8) Nishikawa T, Ohka T, Aoki K et al:Easy-to-use machine learning system for the prediction of IDH mutation and 1p/19q codeletion using MRI images of adult-type diffuse gliomas. Brain Tumor Pathol 40:85-92, 2023

 

9) Lasocki A, Buckland ME, Molinaro T et al:Correlating MRI features with additional genetic markers and patient survival in histological grade 2-3 IDH-mutant astrocytomas. Neuroradiology 65:1215-1223, 2023

 

10) van der Voort SR, Incekara F, Wijnenga MMJ et al:Combined molecular subtyping, grading, and segmentation of glioma using multi-task deep learning. Neuro Oncol 25:279-289, 2023

 

P.5 掲載の参考文献

11) Bouffet E, Hansford JR, Garre ML et al:Dabrafenib plus trametinib in pediatric glioma with BRAF V600 mutations. N Engl J Med 389:1108-1120, 2023

 

12) Brastianos PK, Twohy E, Susan Geyer MS et al:BRAF-MEK inhibition in newly diagnosed papillary craniopharyngiomas. N Engl J Med 389:118-126, 2023

 

13) Mellinghoff IK, van den Bent MJ, Blumenthal DT et al;INDIGO Trial Investigators:Vorasidenib in IDH1- or IDH2-mutant low-grade glioma. N Engl J Med 389:589-601, 2023

 

P.6 掲載の参考文献

14) Tini P, Yavoroska M, Mazzei MA et al:Low expression of Ki-67/MIB-1 labeling index in IDH wild type glioblastoma predicts prolonged survival independently by MGMT methylation status. J Neurooncol 163:339-344, 2023

 

15) Jusue-Torres I, Lee J, Germanwala AV et al:Effect of extent of resection on survival of patients with glioblastoma, IDH-wild-type, WHO grade 4 (WHO 2021):systematic review and meta-analysis. World Neurosurg 171:e524-e532, 2023

 

16) van der Meulen M, Ramos RC, Voisin MR et al:Differences in methylation profiles between long-term survivors and shortterm survivors of IDH-wild-type glioblastoma. Neurooncol Adv 6:vdae001, 2024

 

17) Kros JM, Rushing E, Uwimana AL et al:Mitotic count is prognostic in IDH mutant astrocytoma without homozygous deletion of CDKN2A/B. Results of consensus panel review of EORTC trial 26053 (CATNON) and EORTC trial 22033-26033. Neuro Oncol 25:1443-1449, 2023

 

18) Hervey-Jumper SL, Zhang Y, Phillips JJ et al:Interactive effects of molecular, therapeutic, and patient factors on outcome of diffuse low-grade glioma. J Clin Oncol 41:2029-2042, 2023

 

P.7 掲載の参考文献

19) Louis DN:A vade mecum for crossing the second translational "valley of death" in brain tumor classification. Brain Pathol 34:e13183, 2024

 

P.9 掲載の参考文献

1) Williams EA, Brastianos PK, Wakimoto H et al:A comprehensive genomic study of 390 H3F3A-mutant pediatric and adult diffuse high-grade gliomas, CNS WHO grade 4. Acta Neuropathol 146:515-525, 2023

 

2) Auffret L, Ajlil Y, Tauziede-Espariat A et al:A new subtype of diffuse midline glioma, H3 K27 and BRAF/FGFR1 co-altered:a clinico-radiological and histomolecular characterisation. Acta Neuropathol 147:2, 2023

 

3) Roberts HJ, Ji S, Picca A et al:Clinical, genomic, and epigenomic analyses of H3K27M-mutant diffuse midline glioma long-term survivors reveal a distinct group of tumors with MAPK pathway alterations. Acta Neuropathol 146:849-852, 2023

 

P.10 掲載の参考文献

4) Jessa S, Mohammadnia A, Harutyunyan AS et al:K27M in canonical and noncanonical H3 variants occurs in distinct oligodendroglial cell lineages in brain midline gliomas. Nat Genet 54:1865-1880, 2022

 

5) Liu I, Jiang L, Samuelsson ER et al:The landscape of tumor cell states and spatial organization in H3-K27M mutant diffuse midline glioma across age and location. Nat Genet 54:1881-1894, 2022

 

6) Mo Y, Duan S, Zhang X et al:Epigenome programming by H3.3K27M mutation creates a dependence of pediatric glioma on SMARCA4. Cancer Discov 12:2906-2929, 2022

 

7) Panditharatna E, Marques JG, Wang T et al:BAF complex maintains glioma stem cells in pediatric H3K27M glioma. Cancer Discov 12:2880-2905, 2022

 

8) Harpaz N, Mittelman T, Beresh O et al:Single-cell epigenetic analysis reveals principles of chromatin states in H3.3-K27M gliomas. Mol Cell 82:2696-2713. e9, 2022

 

9) Siddaway R, Canty L, Pajovic S et al:Oncohistone interactome profiling uncovers contrasting oncogenic mechanisms and identifies potential therapeutic targets in high grade glioma. Acta Neuropathol 144:1027-1048, 2022

 

10) Vuong HG, Le HT, Jea A et al:Risk stratification of H3 K27M-mutant diffuse midline gliomas based on anatomical locations:an integrated systematic review of individual participant data. J Neurosurg Pediatr 30:99-106, 2022

 

11) Chai RC, Yan H, An SY et al:Genomic profiling and prognostic factors of H3 K27M-mutant spinal cord diffuse glioma. Brain Pathol 33:e13153, 2023

 

P.11 掲載の参考文献

12) Wang Y, Pan C, Xie M et al:Adult diffuse intrinsic pontine glioma:clinical, radiological, pathological, molecular features, and treatments of 96 patients. J Neurosurg 137:1628-1638, 2022

 

13) Hirano Y, Shinya Y, Aono T et al:The role of stereotactic frame-based biopsy for brainstem tumors in the era of molecular-based diagnosis and treatment decisions. Curr Oncol 29:4558-4565, 2022

 

14) Dalmage M, LoPresti MA, Sarkar P et al:Survival and neurological outcomes after stereotactic biopsy of diffuse intrinsic pontine glioma:a systematic review. J Neurosurg Pediatr 32:665-672, 2023

 

15) Patel J, Aittaleb R, Doherty R et al:Liquid biopsy in H3K27M diffuse midline glioma. Neuro Oncol 26 (Supplement_2):S101-S109, 2024

 

16) Kline C, Jain P, Kilburn L et al:Upfront biology-guided therapy in diffuse intrinsic pontine glioma:therapeutic, molecular, and biomarker outcomes from PNOC003. Clin Cancer Res 28:3965-3978, 2022

 

P.12 掲載の参考文献

17) Grassl N, Poschke I, Lindner K et al:A H3K27M-targeted vaccine in adults with diffuse midline glioma. Nat Med 29:2586-2592, 2023

 

18) Majzner RG, Ramakrishna S, Yeom KW et al:GD2-CAR T cell therapy for H3K27M-mutated diffuse midline gliomas. Nature 603:934-941, 2022

 

19) Ausejo-Mauleon I, Labiano S, de la Nava D et al:TIM-3 blockade in diffuse intrinsic pontine glioma models promotes tumor regression and antitumor immune memory. Cancer Cell 41:1911-1926. e8, 2023

 

20) Venneti S, Kawakibi AR, Ji S et al:Clinical efficacy of ONC201 in H3K27M-mutant diffuse midline gliomas is driven by disruption of integrated metabolic and epigenetic pathways. Cancer Discov 13:2370-2393, 2023

 

21) Arrillaga-Romany I, Gardner SL, Odia Y et al:ONC201 (dordaviprone) in recurrent H3 K27M-mutant diffuse midline glioma. J Clin Oncol 42:1542-1552, 2024

 

22) Arrillaga-Romany I, Lassman A, McGovern SL et al:ACTION:a randomized phase 3 study of ONC201 (dordaviprone) in patients with newly diagnosed H3 K27M-mutant diffuse glioma. Neuro Oncol 26 (Supplement_2):S173-S181, 2024

 

P.13 掲載の参考文献

23) Jackson ER, Duchatel RJ, Staudt DE et al:ONC201 in combination with paxalisib for the treatment of H3K27-altered diffuse midline glioma. Cancer Res 83:2421-2437, 2023

 

24) Izquierdo E, Carvalho DM, Mackay A et al:DIPG harbors alterations targetable by MEK inhibitors, with acquired resistance mechanisms overcome by combinatorial inhibition. Cancer Discov 12:712-729, 2022

 

25) Duchatel RJ, Jackson ER, Parackal SG et al:PI3K/mTOR is a therapeutically targetable genetic dependency in diffuse intrinsic pontine glioma. J Clin Invest 134:e170329, 2024

 

26) Mota M, Sweha SR, Pun M et al:Targeting SWI/SNF ATPases in H3.3K27M diffuse intrinsic pontine gliomas. Proc Natl Acad Sci U S A 120:e2221175120, 2023

 

27) McNicholas M, De Cola A, Bashardanesh Z et al:A compendium of syngeneic, transplantable pediatric high-grade glioma models reveals subtype-specific therapeutic vulnerabilities. Cancer Discov 13:1592-1615, 2023

 

28) van den Bent M, Saratsis AM, Geurts M et al:H3 K27M-altered glioma and diffuse intrinsic pontine glioma:semi-systematic review of treatment landscape and future directions. Neuro Oncol 26 (Supplement_2):S110-S124, 2024

 

29) Gallego Perez-Larraya J, Garcia-Moure M, Labiano S et al:Oncolytic DNX-2401 virus for pediatric diffuse intrinsic pontine glioma. N Engl J Med 386:2471-2481, 2022

 

30) Sasaki T, Watanabe J, He X et al:Intranasal delivery of nanoliposomal SN-38 for treatment of diffuse midline glioma. J Neurosurg 138:1570-1579, 2023

 

P.14 掲載の参考文献

1) Sturm D, Capper D, Andreiuolo F et al:Multiomic neuropathology improves diagnostic accuracy in pediatric neurooncology. Nat Med 29:917-926, 2023

 

P.15 掲載の参考文献

2) White CL, Kinross KM, Moore MK et al:Implementation of DNA methylation array profiling in pediatric central nervous system tumors:the AIM BRAIN Project:an Australian and New Zealand children's haematology/oncology group study. J Mol Diagn 25:709-728, 2023

 

3) Pickles JC, Fairchild AR, Stone TJ et al:DNA methylation-based profiling for paediatric CNS tumour diagnosis and treatment:a population-based study. Lancet Child Adolesc Health 4:121-130, 2020

 

P.16 掲載の参考文献

4) Benhamida JK, Harmsen HJ, Ma D et al:Recurrent TRAK1::RAF1 fusions in pediatric low-grade gliomas. Brain Pathol 33:e13185, 2023

 

5) Lucas CG, Sloan EA, Gupta R et al:Multiplatform molecular analyses refine classification of gliomas arising in patients with neurofibromatosis type 1. Acta Neuropathol 144:747-765, 2022

 

P.17 掲載の参考文献

6) Auffret L, Ajlil Y, Tauziede-Espariat A et al:A new subtype of diffuse midline glioma, H3 K27 and BRAF/FGFR1 coaltered:a clinico-radiological and histomolecular characterisation. Acta Neuropathol 147:2, 2023

 

7) Neyazi S, Yamazawa E, Hack K et al:Transcriptomic and epigenetic dissection of spinal ependymoma (SP-EPN) identifies clinically relevant subtypes enriched for tumors with and without NF2 mutation. Acta Neuropathol 147:22, 2024

 

P.18 掲載の参考文献

8) Sharma T, Schwalbe EC, Williamson D et al:Second-generation molecular subgrouping of medulloblastoma:an international meta-analysis of Group 3 and Group 4 subtypes. Acta Neuropathol 138:309-326, 2019

 

9) Goddard J, Castle J, Southworth E et al:Molecular characterisation defines clinically-actionable heterogeneity within Group 4 medulloblastoma and improves disease risk-stratification. Acta Neuropathol 145:651-666, 2023

 

P.19 掲載の参考文献

10) Li B, Zhao S, Li S et al:Novel molecular subtypes of intracranial germ cell tumors expand therapeutic opportunities. Neuro Oncol 26:1335-1351, 2024

 

P.20 掲載の参考文献

1) Wang J, Cazzato E, Ladewig E et al:Clonal evolution of glioblastoma under therapy. Nat Genet 48:768-776, 2016

 

2) Korber V, Yang J, Barah P et al:Evolutionary trajectories of IDHWT glioblastomas reveal a common path of early tumorigenesis instigated years ahead of initial diagnosis. Cancer Cell 35:692-704. e12, 2019

 

3) Barthel FP, Johnson KC, Varn FS et al;GLASS Consortium:Longitudinal molecular trajectories of diffuse glioma in adults. Nature 576:112-120, 2019

 

4) Varn FS, Johnson KC, Martinek J et al:Glioma progression is shaped by genetic evolution and microenvironment interactions. Cell 185:2184-2199. e16, 2022

 

5) Newman AM, Steen CB, Liu CL et al:Determining cell type abundance and expression from bulk tissues with digital cytometry. Nat Biotechnol 37:773-782, 2019

 

6) Neftel C, Laffy J, Filbin MG et al:An integrative model of cellular states, plasticity, and genetics for glioblastoma. Cell 178:835-849. e21, 2019

 

P.21 掲載の参考文献

7) Hara T, Chanoch-Myers R, Mathewson ND et al:Interactions between cancer cells and immune cells drive transitions to mesenchymal-like states in glioblastoma. Cancer Cell 39:779-792. e11, 2021

 

P.22 掲載の参考文献

8) Malta TM, Sabedot TS, Morosini NS et al:The epigenetic evolution of glioma is determined by the IDH1 mutation status and treatment regimen. Cancer Res 84:741-756, 2024

 

9) Ceccarelli M, Barthel FP, Malta TM et al:Molecular profiling reveals biologically discrete subsets and pathways of progression in diffuse glioma. Cell 164:550-563, 2016

 

10) Mellinghoff IK, van den Bent MJ, Blumenthal DT et al:Vorasidenib in IDH1-or IDH2-mutant low-grade glioma. N Engl J Med 389:589-601, 2023

 

P.23 掲載の参考文献

11) Shirahata M, Ono T, Stichel D et al:Novel, improved grading system (s) for IDH-mutant astrocytic gliomas. Acta Neuropathol 136:153-166, 2018

 

12) Kocakavuk E, Johnson KC, Sabedot TS et al:Hemizygous CDKN2A deletion confers worse survival outcomes in IDHmutnoncodel gliomas. Neuro Oncol 25:1721-1723, 2023

 

13) Sottoriva A, Spiteri I, Piccirillo SG et al:Intratumor heterogeneity in human glioblastoma reflects cancer evolutionary dynamics. Proc Natl Acad Sci U S A 110:4009-4014, 2013

 

14) Suzuki H, Aoki K, Chiba K et al:Mutational landscape and clonal architecture in grade II and III gliomas. Nat Genet 47:458-468, 2015

 

15) Mathur R, Wang Q, Schupp PG et al:Glioblastoma evolution and heterogeneity from a 3D whole-tumor perspective. Cell 187:446-463. e16, 2024

 

16) Karschnia P, Young JS, Dono A et al:Prognostic validation of a new classification system for extent of resection in glioblastoma:a report of the RANO resect group. Neuro Oncol 25:940-954, 2023

 

P.24 掲載の参考文献

17) Appin CL, Hong C, Suwala AK et al:Whole tumor analysis reveals early origin of the TERT promoter mutation and intercellular heterogeneity in TERT expression. Neuro Oncol 26:640-652, 2024

 

18) Higa N, Akahane T, Yokoyama S et al:A tailored next-generation sequencing panel identified distinct subtypes of wildtype IDH and TERT promoter glioblastomas. Cancer Sci 111:3902-3911, 2020

 

19) Nakashima T, Yamamoto R, Ohno M et al:Development of a rapid and comprehensive genomic profiling test supporting diagnosis and research for gliomas. Brain Tumor Pathol 41:50-60, 2024

 

20) Miller AM, Shah RH, Pentsova EI et al:Tracking tumour evolution in glioma through liquid biopsies of cerebrospinal fluid. Nature 565:654-658, 2019

 

21) Hayashi T, Tateishi K, Matsuyama S et al:Intraoperative integrated diagnostic system for malignant central nervous system tumors. Clin Cancer Res 30:116-126, 2024

 

22) Vermeulen C, Pages-Gallego M, Kester L et al:Ultra-fast deep-learned CNS tumour classification during surgery. Nature 622:842-849, 2023

 

P.25 掲載の参考文献

23) Satomi K, Ichimura K, Shibahara J:Decoding the DNA methylome of central nervous system tumors:an emerging modality for integrated diagnosis. Pathol Int 74:51-67, 2024

 

24) Otani Y, Satomi K, Suruga Y et al:Utility of genome-wide DNA methylation profiling for pediatric-type diffuse gliomas. Brain Tumor Pathol 40:56-65, 2023

 

25) Hadad S, Gupta R, Oberheim Bush NA et al:"De novo replication repair deficient glioblastoma, IDH-wildtype" is a distinct glioblastoma subtype in adults that may benefit from immune checkpoint blockade. Acta Neuropathol 147:3, 2024

 

P.26 掲載の参考文献

1) Ito S, Nakashima H, Segi N et al:Automated detection and diagnosis of spinal schwannomas and meningiomas using deep learning and magnetic resonance imaging. J Clin Med 12:5057, 2023

 

2) Zhuo Z, Zhang J, Duan Y et al:Automated classification of intramedullary spinal cord tumors and inflammatory demyelinating lesions using deep learning. Radiol Artif Intell 4:e210292, 2022

 

P.27 掲載の参考文献

3) Song C, Kim HS, Lee JH et al:Development of a novel prediction model for differential diagnosis between spinal myxopapillary ependymoma and schwannoma. Sci Rep 14:149, 2024

 

4) Endo T, Inoue T, Mizuno M et al;Investigators of intramedullary spinal cord tumors in the Neurospinal Society of Japan:Current trends in the surgical management of intramedullary tumors:a multicenter study of 1,033 patients by Neurospinal Society of Japan. Neurospine 19:441-452, 2022

 

P.28 掲載の参考文献

5) Watanabe G, Wong JM, Estes B et al:Diffuse midline H3K27-altered gliomas in the spinal cord:a systematic review. J Neurooncol 166:379-394, 2024

 

6) Zhang F, Cheng L, Ding Z et al:Dose H3K27M mutation impact survival outcome of high-grade spinal cord astrocytoma? Neurospine 20:1480-1489, 2023

 

P.29 掲載の参考文献

7) Naito K, Umebayashi D, Kurokawa R et al;study group of intramedullary spinal cord tumors in the Neurospinal Society of Japan:Predictors of progression-free survival in patients with spinal intramedullary ependymoma:a multicenter retorospective study by the Neurospinal Society of Japan. Neurosurgery 93:1046-1056, 2023

 

8) Alhalabi OT, Heene S, Landre V et al:Association of early surgery and absence of ataxia with full recovery after spinal intramedullary ependymoma resection. J Neurosurg Spine 40:185-195, 2023

 

9) Chaskis E, Bouchaala M, David P et al:Long-term outcomes after incomplete resection of intramedullary grade II ependymomas:is adjuvant radiotherapy justified? Cancers (Basel) 15:3674, 2023

 

P.30 掲載の参考文献

10) Kanematsu R, Mizuno M, Inoue T et al;Investigators of Intramedullary Spinal Cord Tumors in the Neurospinal Society of Japan:The impact of adjuvant radiotherapy on clinical performance status in patients with grade II spinal cord astrocytoma - a nationwide analysis by the Neurospinal Society of Japan. Neurospine 20:766-773, 2023

 

11) Muto J, Murata H, Shigekawa S et al;Investigators of Intramedullary Spinal Cord Tumors in the Neurospinal Society of Japan:Clinical characteristics and long-term outcomes of spinal pilocytic astrocytomas:a multicenter retrospective study by the Neurospinal Society of Japan. Neurospine 20:774-782, 2023

 

12) Inoue T, Endo T, Muto J et al;Investigators of Intramedullary Spinal Cord Tumors in the Neurospinal Society of Japan:Shorter survival time of adolescents and young adult patients than older adults with spinal cord glioblastoma:a multicenter study. J Neurosurg Spine 40:196-205, 2023

 

P.31 掲載の参考文献

13) Amelot A, Terrier LM, Mathon B et al;Medullary Glioblastoma study group:Natural course and prognosis of primary spinal glioblastoma:a nationwide study. Neurology 100:e1497-e1509, 2023

 

14) Takeshima Y, Takami H, Endo T et al;Investigators of Intramedullary Spinal Cord Tumors in the Neurospinal Society of Japan:Comparison of recurrence and surgical outcome of spinal hemangioblastoma in sporadic and von Hippel-Lindau diseases:a subanalysis of a nationwide study by the Neurospinal Society of Japan. Neurospine 20:756-765, 2023

 

15) Schwake M, Ricchizzi S, Krahwinkel S et al:Resection of intramedullary hemangioblastoma:timing of surgery and its impact on neurological outcome and quality of life. Medicina (Kaunas) 59:1611, 2023

 

16) Butenschoen VM, Schwendner M, Hubertus V et al:Preoerative angiographic considerations and neurological outcome after surgical treatment of intradural spinal hemangioblastoma:a multicenter retrospective case series. J Neurooncol 161:107-115, 2023

 

P.32 掲載の参考文献

17) Kurokawa R, Endo T, Takami T;Investigators of Intramedullary Spinal Cord Tumors in the Neurospinal Society of Japan:Acceptance of early surgery for treatment of spinal cord cavernous malformation in contemporary Japan. Neurospine 20:587-594, 2023

 

18) Srinivasan VM, Karahalios K, Shlobin N et al:Residual and recurrent spinal cord cavernous malformations:outcomes and techniques to optimize resection and a systematic review of the literature. Oper Neurosurg (Hagerstown) 24:44-54, 2023

 

P.33 掲載の参考文献

19) Jankovic D, Kalasauskas D, Othman A et al:Predictors of neurological worsening after resection of spinal meningiomas. Cancers (Basel) 15:5408, 2023

 

20) Sarikaya C, Ramazanoglu AF, Yaltirik CK et al:Short-term results of Simpson grade 2 resection in spinal meningiomas. World Neurosurg 171:e792-e795, 2023

 

21) Takahashi T, Hirai T, Yoshii T et al:Risk factors for recurrence and regrowth of spinal schwannoma. J Orthop Sci 28:554-559, 2023

 

P.34 掲載の参考文献

22) Singh A, Fletcher-Sandersjoo A, El-Hajj VG et al:Long-term functional outcomes following surgical treatment of spinal schwannomas:a population-based cohort study. Cancers (Basel) 16:519, 2024

 

23) Liu Z, Xu Z, Shen J et al:Scoring model to predict postoperative neurological deterioration in spinal schwannoma. Front Oncol 13:1086299, 2023

 

P.36 掲載の参考文献

1) Ehret F, Perez E, Teichmann D et al:Clinical implications of DNA methylationbased integrated classification of histologically defined grade 2 meningiomas. Acta Neuropathol Commun 12:74, 2024

 

2) Driver J, Hoffman SE, Tavakol S et al:A molecularly integrated grade for meningioma. Neuro Oncol 24:796-808, 2021

 

3) Maas SLN, Sievers P, Weber DC et al:Independent prognostic impact of DNA methylation class and chromosome 1p loss in WHO grade 2 and 3 meningioma undergoing adjuvant high-dose radiotherapy:comprehensive molecular analysis of EORTC 22042-26042. Acta Neuropathol 146:837-840, 2023

 

4) Chen WC, Choudhury A, Youngblood MW et al:Targeted gene expression profiling predicts meningioma outcomes and radiotherapy responses. Nat Med 29:3067-3076, 2023

 

P.37 掲載の参考文献

5) Sasaki S, Takeda M, Hirose T et al:Correlation of MTAP immunohistochemistry with CDKN2A status assessed by fluorescence in situ hybridization and clinicopathological features in CNS WHO grade 2 and 3 meningiomas:a single center cohort study. J Neuropathol Exp Neurol 81:117-126, 2022

 

6) Ren L, Cheng H, Chen J et al:Progesterone receptor expression and prediction of benefits of adjuvant radiotherapy in de novo atypical meningiomas after gross-total resection. J Neurosurg 139:49-58, 2022

 

7) Nassiri F, Liu J, Patil V et al:A clinically applicable integrative molecular classification of meningiomas. Nature 597:119-125, 2021

 

8) Deng MY, Maas SLN, Hinz F et al:Efficacy and toxicity of bimodal radiotherapy in WHO grade 2 meningiomas following subtotal resection with carbon ion boost:prospective phase 2 MARCIE trial. Neuro Oncol 26:701-712, 2024

 

9) Teranishi Y, Miyawaki S, Nakatochi M et al:Meningiomas in patients with neurofibromatosis type 2 predominantly comprise 'immunogenic subtype' tumours characterised by macrophage infiltration. Acta Neuropathol Commun 11:156, 2023

 

P.38 掲載の参考文献

10) Choudhury A, Magill ST, Eaton CD et al:Meningioma DNA methylation groups identify biological drivers and therapeutic vulnerabilities. Nat Genet 54:649-659, 2022

 

11) Juratli TA, Jones PS, Wang N et al:Targeted treatment of papillary craniopharyngiomas harboring BRAF V600E mutations. Cancer 125:2910-2914, 2019

 

12) Brastianos PK, Twohy E, Geyer S et al:BRAF-MEK inhibition in newly diagnosed papillary craniopharyngiomas. N Engl J Med 389:118-126, 2023

 

P.39 掲載の参考文献

13) Fujio S, Juratli TA, Arita K et al:A clinical rule for preoperative prediction of BRAF mutation status in craniopharyngiomas. Neurosurgery 85:204-210, 2019

 

14) Huang Z, Xiao X, Li X et al:Machine learning-based multiparametric magnetic resonance imaging radiomic model for discrimination of pathological subtypes of craniopharyngioma. J Magn Reson Imaging 54:1541-1550, 2021

 

15) Plotkin SR, Messiaen L, Legius E et al:Updated diagnostic criteria and nomenclature for neurofibromatosis type 2 and schwannomatosis:an international consensus recommendation. Genet Med 24:1967-1977, 2022

 

16) Hannan CJ, Lewis D, O'Leary C et al:The inflammatory microenvironment in vestibular schwannoma. Neurooncol Adv 2:vdaa023, 2020

 

17) Liu SJ, Casey-Clyde T, Cho NW et al:Epigenetic reprogramming shapes the cellular landscape of schwannoma. Nat Commun 15:476, 2024

 

P.41 掲載の参考文献

1) Villa C, Baussart B, Assie G et al:The World Health Organization classifications of pituitary neuroendocrine tumours:a clinico-pathological appraisal. Endocr Relat Cancer 30:e230021, 2023

 

2) Ho KKY, Kaiser UB, Chanson P et al:Pituitary adenoma or neuroendocrine tumour:the need for an integrated prognostic classification. Nat Rev Endocrinol 19:671-678, 2023

 

P.42 掲載の参考文献

3) Inoshita N, Yoshimoto T, Takazawa Y et al:Immunohistochemical and ultrastructural review of six cases previously diagnosed as null cell PitNETs. Brain Tumor Pathol 40:158-162, 2023

 

4) Sahakian N, Appay R, Resseguier N et al:Real-life clinical impact of a five-tiered classification of pituitary tumors. Eur J Endocrinol 187:893-904, 2022

 

5) Ho KKY, Fleseriu M, Wass J et al:A proposed clinical classification for pituitary neoplasms to guide therapy and prognosis. Lancet Diabetes Endocrinol 12:209-214, 2024

 

6) Saeger W, Mawrin C, Meinhardt M et al:Two pituitary neuroendocrine tumors (PitNETs) with very high proliferation and TP53 mutation - high-grade PitNET or PitNEC? Endocr Pathol 33:257-262, 2022

 

7) Nishioka H:Aggressive pituitary tumors (PitNET). Endocrine J 70:241-248, 2023

 

8) Raymond P, Raverot G, Ilie MD:Outcome and prognostic factors for pituitary carcinomas:lessons from a systematic review. Endocr Relat Cancer 30:e220338, 2023

 

P.43 掲載の参考文献

9) Ilie MD, De Alcubierre D, Carretti AL et al:Therapeutic targeting of the pituitary tumor microenvironment. Pharmacol Ther 250:108506, 2023

 

10) Jimenez AE, Azad TD, Mukherjee D:Decreasing reimbursement of pituitary tumor surgery:an analysis of Medicare data from 2010 to 2020. Neurosurgery 94:140-146, 2024

 

11) Candy NG, Ovenden C, Jukes AK et al:The learning curve for endoscopic endonasal pituitary surgery:a systematic review. Neurosurg Rev 46:241, 2023

 

12) cerny M, Sedlak V, Lesakova V et al:Methods of preoperative prediction of pituitary adenoma consistency:a systematic review. Neurosurg Rev 46:11, 2023

 

13) Muto J, Mine Y, Nishiyama Y et al:Intraoperative real-time near-infrared image-guided endoscopic endonasal surgery for pituitary tumors. World Neurosurg 175:e218-e229, 2023

 

14) Castle-Kirszbaum M, Wang YY, King J et al:Quality of life and surgical outcomes in incidental pituitary adenomas undergoing endoscopic endonasal resection. J Neurosurg 138:567-573, 2022

 

P.44 掲載の参考文献

15) Pontes JPM, Udoma-Udofa OC, de Oliveira JS et al:Efficacy and safety of cavernous sinus medial wall resection in pituitary adenoma surgery:a systematic review and a single-arm meta-analysis. Pituitary 26:340-351, 2023

 

16) Xiao L, Ouyang T, Wu B et al:Subclassification of Knosp grade 4 pituitary adenoma:bringing insights into the significance of tumor growth pathways. Neurosurgery 92:213-222, 2023

 

17) Zhang S, Yao S, Chen J et al:Correlation between tumor invasion and somatostatin receptor subtypes in acromegaly. J Neurosurg 6:1019-1028, 2023

 

18) Ironside N, Chen CJ, Xu Z et al:Effects of neuroanatomic structural distances on pituitary function after stereotactic radiosurgery:a multicenter study. Neurosurgery 92:1035-1042, 2023

 

19) Sathe AV, Siu A, Kang KC et al:Early versus delayed fractionated stereotactic radiotherapy for nonfunctioning pituitary adenoma. World Neurosurg 180:e317-e323, 2023

 

P.45 掲載の参考文献

20) Mamelak AN, Little AS, Gardner PA et al:A prospective, multicenter, observational study of surgical vs nonsurgical management for pituitary apoplexy. J Clin Endocrinol Metab 109:e711-e725, 2024

 

21) Oda Y, Amano K, Masui K et al:Clinical features of pituitary or parasellar tumor onset with cranial nerve palsy:surgical intervention considerations. World Neurosurg 175:e832-e840, 2023

 

22) Giustina A, Biermasz N, Casanueva FF et al:Consensus on criteria for acromegaly diagnosis and remission. Pituitary 27:7-22, 2024

 

23) Fleseriu M, Barkan A, Schneider MdP et al:Prevalence of comorbidities and concomitant medication use in acromegaly:analysis of real-world data from the United States. Pituitary 25:296-307, 2022

 

24) Petersenn S, Fleseriu M, Casanueva FF et al:Diagnosis and management of prolactin-secreting pituitary adenomas:a Pituitary society international Consensus Statement. Nat Rev Endocrinol 19:722-740, 2023

 

P.46 掲載の参考文献

25) Fleseriu M, Varlamov EV, Hinojosa-Amaya JM et al:An individualized approach to the management of Cushing disease. Nat Rev Endocrinol 19:581-599, 2023

 

26) Graffeo CS, Yagnik KJ, Carlstrom LP et al:Pituitary adenoma incidence, management trends, and long-term outcomes:a 30-year population-based analysis. Mayo Clin Proc 97:1861-1871, 2022

 

27) Botelho MS, Franzini IA, Nunes-Nogueira VDS et al:Treatment of non-functioning pituitary adenoma with cabergoline:a systematic review and meta-analysis. Pituitary 25:810-818, 2022

 

28) Coopmans EC, Korbonits M:Molecular genetic testing in the management of pituitary disease. Clin Endocrinol (Oxf) 97:424-435, 2022

 

II章 脳血管障害

P.49 掲載の参考文献

1) Jeon JP, Hong EP, Ha EJ et al:Genome-wide association study identifies novel susceptibilities to adult moyamoya disease. J Hum Genet 68:713-720, 2023

 

2) Nomura S, Akagawa H, Yamaguchi K et al:Difference in clinical phenotype, mutation position, and structural change of RNF213 rare variants between pediatric and adult Japanese patients with moyamoya disease. Transl Stroke Res, 2023. doi:10.1007/s12975-023-01194-w.

 

3) Wang Y, Zou Z, Yang Z et al:Whole exome sequencing and functional validation identify CAPN1 variants as a cause of Chinese moyamoya disease. Genes Dis 11:101090, 2024

 

4) Ikeuchi Y, Kitayama J, Sahara N et al:Filamin A variant as a possible secondhit gene promoting moyamoya diseaselike vascular formation associated with RNF213 p. R4810K variant. Neurol Genet 8:e200017, 2022

 

5) Pinard A, Ye W, Fraser SM et al:Rare variants in ANO1, encoding a calcium-activated chloride channel, predispose to moyamoya disease. Brain 146:3616-3623, 2023

 

6) He S, Hao X, Liu Z et al:Association between DIAPH1 variant and posterior circulation involvement with Moyamoya disease. Sci Rep 13:10732, 2023

 

P.50 掲載の参考文献

7) Guey S, Herve D, Kossorotoff M et al:Biallelic variants in NOS3 and GUCY1A3, the two major genes of the nitric oxide pathway, cause moyamoya cerebral angiopathy. Hum Genomics 17:24, 2023

 

8) Chen J, Zheng H, Wu X et al:Neuregulin 1 as a potential biomarker for disease progression in moyamoya disease:a casecontrol study in Chinese population. J Stroke Cerebrovasc Dis 33:107581, 2024

 

9) Ito M, Kawabori M, Sugiyama T et al:Impact of RNF213 founder polymorphism (p. R4810K) on the postoperative development of indirect pial synangiosis after direct/indirect combined revascularization surgery for adult Moyamoya disease. Neurosurg Rev 45:2305-2313, 2022

 

10) Kawabori M, Ito M, Kazumata K et al:Impact of RNF213 c. 14576G>A variant on the development of direct and indirect revascularization in pediatric moyamoya disease. Cerebrovasc Dis 52:171-176, 2023

 

11) Torazawa S, Miyawaki S, Imai H et al:Association of genetic variants with postoperative donor artery development in moyamoya disease:RNF213 and other moyamoya angiopathy-related gene analysis. Transl Stroke Res, 2024. doi:10.1007/s12975-024-01248-7

 

12) Uchino H, Ito M, Tokairin K et al:Association of RNF213 polymorphism and cortical hyperintensity sign on fluid-attenuated inversion recovery images after revascularization surgery for moyamoya disease:possible involvement of intrinsic vascular vulnerability. Neurosurg Rev 46:119, 2023

 

13) Gao G, Bao XY, Wang QN et al:Association between polymorphism in the MTHFR gene and encephaloduroarteriosynangiosis-induced collateral circulation formation. J Neurosurg, 2024. doi:10.3171/2024.1.JNS232121

 

14) Mineharu Y, Takagi Y, Koizumi A et al:Posterior cerebral artery involvement in unilateral moyamoya disease is exclusively ipsilateral and influenced by RNF213 mutation gene dose:the SUPRA Japan study:PCA involvement in unilateral moyamoya. J Stroke Cerebrovasc Dis 33:107513, 2024

 

P.51 掲載の参考文献

15) Xue Y, Zeng C, Ge P et al:Association of RNF213 variants with periventricular anastomosis in moyamoya disease. Stroke 53:2906-2916, 2022

 

16) Torazawa S, Miyawaki S, Imai H et al:RNF213 p. Arg4810Lys wild type is associated with de novo hemorrhage in asymptomatic hemispheres with moyamoya disease. Transl Stroke Res, 2023. doi:10.1007/s12975-023-01159-z

 

17) Ozaki D, Endo H, Tashiro R et al:Association between RNF213 c. 14576G>A variant (rs112735431) and peripheral pulmonary artery stenosis in moyamoya disease. Cerebrovasc Dis 51:282-287, 2022

 

18) Yajima H, Miyawaki S, Sayama S et al:Hypertensive disorders of pregnancy in moyamoya disease:a single institution experience. J Stroke Cerebrovasc Dis 32:107377, 2023

 

19) Hiruma M, Watanabe N, Mitsumatsu T et al:Clinical features of moyamoya disease with Graves' disease:a retrospective study of 394,422 patients with thyroid disease. Endocr J 70:141-148, 2023

 

20) Kuroda S, Fujimura M, Takahashi J et al:Diagnostic criteria for moyamoya disease - 2021 revised version. Neurol Med Chir (Tokyo) 62:307-312, 2022

 

21) Thamamongood T, Hara S, Akagawa H et al:Synergistic interaction of thyroid autoantibodies and ring finger protein 213 variant in moyamoya disease. Neurol Med Chir (Tokyo) 64:43-49, 2024

 

P.52 掲載の参考文献

22) Yoshimoto T, Ishiyama H, Hattori Y et al:Association of thyroid peroxidase antibody with the RNF213 p. R4810K variant in ischemic stroke/transient ischemic attack. Atherosclerosis 382:117281, 2023

 

23) Hong T, Xiao X, Ren J et al:Somatic MAP3K3 and PIK3CA mutations in sporadic cerebral and spinal cord cavernous malformations. Brain 144:2648-2658, 2021

 

P.53 掲載の参考文献

24) Wang J, Tang J, Yang Y et al:Genotypephenotype correlations in multiple lesions of familial cerebral cavernous malformations concerning phosphatidylinositol 3-kinase catalytic subunit alpha mutations. Clin Transl Med 14:e1610, 2024

 

25) Li L, Ren AA, Gao S et al:mTORC1 inhibitor rapamycin inhibits growth of cerebral cavernous malformation in adult mice. Stroke 54:2906-2917, 2023

 

26) Snellings DA, Girard R, Lightle R et al:Developmental venous anomalies are a genetic primer for cerebral cavernous malformations. Nat Cardiovasc Res 1:246-252, 2022

 

P.54 掲載の参考文献

1) Kim T, Lee H, Ahn S et al:Incidence and risk factors of intracranial aneurysm:a national cohort study in Korea. Int J Stroke 11:917-927, 2016

 

P.55 掲載の参考文献

2) Heo J, Park SJ, Kang SH et al:Prediction of intracranial aneurysm risk using machine learning. Sci Rep 10:6921, 2020

 

3) Kim T, Choi J, Park WJ et al:Validation of prediction algorithm for risk estimation of intracranial aneurysm development using real-world data. Sci Rep 13:14651, 2023

 

4) Xiong Y, Zheng Y, Yan Y et al:Circulating proteomic panels for risk stratification of intracranial aneurysm and its rupture. EMBO Mol Med 14:e14713, 2022

 

P.56 掲載の参考文献

5) Poppenberg KE, Chien A, Santo BA et al:Profiling of circulating gene expression reveals molecular signatures associated with intracranial aneurysm rupture risk. Mol Diagn Ther 27:115-127, 2023

 

6) Din M, Agarwal S, Grzeda M et al:Detection of cerebral aneurysms using artificial intelligence:a systematic review and meta-analysis. J Neurointerv Surg 15:262-271, 2023

 

7) Kuwabara M, Ikawa F, Sakamoto S et al:Effectiveness of tuning an artificial intelligence algorithm for cerebral aneurysm diagnosis:a study of 10,000 consecutive cases. Sci Rep 13:16202, 2023

 

P.57 掲載の参考文献

8) Tan J, Song R, Su J et al:Establishment and multicenter external validation of a risk prediction model for de novo intracranial aneurysms based on a systematic review and meta-analysis of 19 cohorts. J Neurosurg 140:783-791, 2024

 

9) Matano F, Mizunari T, Murai Y et al:White matter lesions as brain frailty and age are risk factors for surgical clipping of unruptured intracranial aneurysms in the elderly. J Stroke Cerebrovasc Dis 29:105121, 2020

 

P.58 掲載の参考文献

10) Rodrigues RS, Rabelo NN, Telles JPM et al:Sarcopenia as a predictor of the functional outcome in patients with intracranial aneurysms. Gerontology 69:65-72, 2023

 

11) Kuwabara M, Ikawa F, Michihata N et al:The 5-factor modified frailty index as a more useful associated factor than chronological age after unruptured cerebral aneurysm surgery:a nationwide registry study. Neurosurgery 92:329-337, 2023

 

12) Stroh N, Stefanits H, Maletzky A et al:Machine learning based outcome prediction of microsurgically treated unruptured intracranial aneurysms. Sci Rep 13:22641, 2023

 

P.59 掲載の参考文献

13) Liu Q, Li J, Zhang Y et al:Association of calcium channel blockers with lower incidence of intracranial aneurysm rupture and growth in hypertensive patients. J Neurosurg 139:651-660, 2023

 

14) Jabbarli R, Darkwah Oppong M, Chihi M et al:Regular medication as a risk factor for intracranial aneurysms:a comparative case-control study. Eur Stroke J 8:251-258, 2023

 

P.60 掲載の参考文献

1) Mohr JP, Parides MK, Stapf C et al;international ARUBA investigators:Medical management with or without interventional therapy for unruptured brain arteriovenous malformations (ARUBA):a multicentre, non-blinded, randomised trial. Lancet 383:614-621, 2014

 

P.61 掲載の参考文献

2) Mohr JP, Overbey JR, Hartmann A et al;ARUBA co-investigators:Medical management with interventional therapy versus medical management alone for unruptured brain arteriovenous malformations (ARUBA):final follow-up of a multicentre, non-blinded, randomised controlled trial. Lancet Neurol 19:573-581, 2020

 

3) Al-Shahi Salman R, White PM, Counsell CE et al;Scottish Audit of Intracranial Vascular Malformations Collaborators:Outcome after conservative management or intervention for unruptured brain arteriovenous malformations. JAMA 311:1661-1669, 2014

 

4) Derdeyn CP, Zipfel GJ, Albuquerque FC et al;American Heart Association Stroke Council:Management of brain arteriovenous malformations:a scientific statement for healthcare professionals from the American Heart Association/American Stroke Association. Stroke 48:e200-e224, 2017

 

P.62 掲載の参考文献

5) Pezeshkpour P, Dmytriw AA, Phan K et al:Treatment strategies and related outcomes for brain arteriovenous malformations in children:a systematic review and meta-analysis. AJR Am J Roentgenol 215:472-487, 2020

 

6) Lu VM, Wahood W, Rinaldo L et al:Longterm functional outcome after intervention for pediatric intracranial arteriovenous malformations:a systematic review and meta-analysis. Clin Neurol Neurosurg 191:105707, 2020

 

7) Borcek Ao, Celtikci E, Aksogan Y et al:Clinical outcomes of stereotactic radiosurgery for cerebral arteriovenous malformations in pediatric patients:systematic review and meta-analysis. Neurosurgery 85:E629-E640, 2019

 

8) Wu EM, El Ahmadieh TY, McDougall CM et al:Embolization of brain arteriovenous malformations with intent to cure:a systematic review. J Neurosurg 132:388-399, 2019

 

9) Dabhi N, Sokolowski J, Zanaty M et al:Primary embolization of cerebral arteriovenous malformations with intention to cure:a systematic review of literature and meta-analysis. Neurosurgery, 2024. doi:10.1227/neu.0000000000003001

 

10) Maroufi SF, Fallahi MS, Khorasanizadeh M et al:radiosurgery with prior embolization versus radiosurgery alone for intracranial arteriovenous malformations:a systematic review and meta-analysis. Neurosurgery 94:478-496, 2024

 

11) Jiang Z, Zhang X, Wan X et al:Efficacy and safety of combined endovascular embolization and stereotactic radiosurgery for patients with intracranial arteriovenous malformations:a systematic review and meta-analysis. Biomed Res Int 2021:6686167, 2021

 

12) Chang H, Silva MA, Weng J et al:The impact of embolization on radiosurgery obliteration rates for brain arteriovenous malformations:a systematic review and meta-analysis. Neurosurg Rev 46:28, 2022

 

P.63 掲載の参考文献

13) Ilyas A, Chen CJ, Abecassis IJ et al:stereotactic radiosurgery for a randomized trial of unruptured brain arteriovenous malformations-eligible patients:a meta-analysis. Neurosurgery 91:684-692, 2022

 

14) Jiang X, Zhao Z, Zhang Y et al:Preradiosurgery embolization in reducing the postoperative hemorrhage rate for patients with cerebral arteriovenous malformations:a systematic review and meta-analysis. Neurosurg Rev 44:3197-3207, 2021

 

15) Mamaril-Davis JC, Aguilar-Salinas P, Avila MJ et al:Complete seizure-free rates following interventional treatment of intracranial arteriovenous malformations:a systematic review and meta-analysis. Neurosurg Rev 45:1313-1326, 2022

 

16) Koester SW, Batista S, Bertani R et al:Angiographic factors leading to hemorrhage in AVMs:a systematic review and meta-analysis. Neurosurg Rev 46:72, 2023

 

17) de Liyis BG, Arini AAIK, Karuniamaya CP et al:Risk of intracranial hemorrhage in brain arteriovenous malformations:a systematic review and meta-analysis. J Neurol 271:2274-2284, 2024

 

18) Orscelik A, Musmar B, Matsukawa H et al:Optimal timing of microsurgical treatment for ruptured arteriovenous malformations:a systematic review and meta-analysis. Neurosurgery, 2024. doi:10.1227/neu.0000000000003043

 

19) Chye CL, Wang KW, Chen HJ et al:Haemorrhage rates of ruptured and unruptured brain arteriovenous malformation after radiosurgery:a nationwide population-based cohort study. BMJ Open 10:e036606, 2020

 

20) Davidoff CL, Lo Presti A, Rogers JM et al:Risk of first hemorrhage of brain arteriovenous malformations during pregnancy:a systematic review of the literature. Neurosurgery 85:E806-E814, 2019

 

21) Nikolaev SI, Vetiska S, Bonilla X et al:Somatic activating KRAS mutations in arteriovenous malformations of the brain. N Engl J Med 378:250-261, 2018

 

22) Al-Olabi L, Polubothu S, Dowsett K et al:Mosaic RAS/MAPK variants cause sporadic vascular malformations which respond to targeted therapy. J Clin Invest 128:5185, 2018

 

P.64 掲載の参考文献

23) Hong T, Yan Y, Li J et al:High prevalence of KRAS/BRAF somatic mutations in brain and spinal cord arteriovenous malformations. Brain 142:23-34, 2019

 

24) Goss JA, Huang AY, Smith E et al:Somatic mutations in intracranial arteriovenous malformations. PLoS One 14:e0226852, 2019

 

25) Priemer DS, Vortmeyer AO, Zhang S et al:Activating KRAS mutations in arteriovenous malformations of the brain:frequency and clinicopathologic correlation. Hum Pathol 89:33-39, 2019

 

26) Oka M, Kushamae M, Aoki T et al:KRAS G12D or G12V mutation in human brain arteriovenous malformations. World Neurosurg 126:e1365-e1373, 2019

 

27) Couto JA, Huang AY, Konczyk DJ et al:Somatic MAP2K1 mutations are associated with extracranial arteriovenous malformation. Am J Hum Genet 100:546-554, 2017

 

28) Goss JA, Konczyk DJ, Smits PJ et al:Intramuscular fast-flow vascular anomaly contains somatic MAP2K1 and KRAS mutations. Angiogenesis 22:547-552, 2019

 

29) Raymond J, Gentric JC, Magro E et al;TOBAS Collaborative Group;Collaborators in the TOBAS Collaborative Group:Endovascular treatment of brain arteriovenous malformations:clinical outcomes of patients included in the registry of a pragmatic randomized trial. J Neurosurg 138:1393-1402, 2022

 

30) Darsaut TE, Magro E, Bojanowski MW et al;TOBAS Collaborative Group;List of participating TOBAS centers and physicians:Surgical treatment of brain arteriovenous malformations:clinical outcomes of patients included in the registry of a pragmatic randomized trial. J Neurosurg 138:891-899, 2022

 

31) Fish JE, Flores-Suarez CP, Boudreau E et al:Somatic gain of KRAS function in the endothelium is sufficient to cause vascular malformations that require MEK but not PI3K signaling. Circ Res 127:727-743, 2020

 

32) Bameri O, Salarzaei M, Parooie F:KRAS/BRAF mutations in brain arteriovenous malformations:a systematic review and meta-analysis. Interv Neuroradiol 27:539-546, 2021

 

33) Patel BG, Ahmed KA, Johnstone PA et al:Initial experience with combined BRAF and MEK inhibition with stereotactic radiosurgery for BRAF mutant melanoma brain metastases. Melanoma Res 26:382-386, 2016

 

P.65 掲載の参考文献

34) Lekwuttikarn R, Lim YH, Admani S et al:Genotype-guided medical treatment of an arteriovenous malformation in a child. JAMA Dermatol 155:256-257, 2019

 

35) Maynard K, LoPresti M, Iacobas I et al:Antiangiogenic agent as a novel treatment for pediatric intracranial arteriovenous malformations:case report. J Neurosurg Pediatr 24:673-679, 2019

 

36) Akers A, Al-Shahi Salman R, A Awad I et al:Synopsis of guidelines for the clinical management of cerebral cavernous malformations:consensus recommendations based on systematic literature review by the Angioma Alliance Scientific Advisory Board Clinical Experts Panel. Neurosurgery 80:665-680, 2017

 

37) Gao X, Yue K, Sun J et al:Treatment of cerebral cavernous malformations presenting with seizures:a systematic review and meta-analysis. Front Neurol 11:590589, 2020

 

38) Lanfranconi S, Scola E, Meessen JMTA et al;Treat_CCM Investigators:Safety and efficacy of propranolol for treatment of familial cerebral cavernous malformations (Treat_CCM):a randomised, openlabel, blinded-endpoint, phase 2 pilot trial. Lancet Neurol 22:35-44, 2023

 

39) CARE pilot trial collaboration:Medical management and surgery versus medical management alone for symptomatic cerebral cavernous malformation (CARE):a feasibility study and randomised, open, pragmatic, pilot phase trial. Lancet Neurol 23:565-576, 2024

 

P.66 掲載の参考文献

40) 日本脳卒中学会脳卒中ガイドライン委員会編:脳卒中治療ガイドライン2021〔改訂2023〕. 協和企画, 2023

 

P.67 掲載の参考文献

1) Kuroda S, Yamamoto S, Funaki T et al;AMORE Study Group:Five-year stroke risk and its predictors in asymptomatic moyamoya disease:Asymptomatic Moyamoya Registry (AMORE). Stroke 54:1494-1504, 2023

 

P.68 掲載の参考文献

2) Funaki T, Takahashi JC, Houkin K et al:High rebleeding risk associated with choroidal collateral vessels in hemorrhagic moyamoya disease:analysis of a nonsurgical cohort in the Japan Adult Moyamoya Trial. J Neurosurg 130:525-530, 2019

 

3) Funaki T, Takahashi JC, Houkin K et al:Effect of choroidal collateral vessels on de novo hemorrhage in moyamoya disease:analysis of nonhemorrhagic hemispheres in the Japan Adult Moyamoya Trial. J Neurosurg 132:408-414, 2019

 

4) Miyakoshi A, Funaki T, Fushimi Y et al:Cortical distribution of fragile periventricular anastomotic collateral vessels in moyamoya disease:an exploratory crosssectional study of Japanese patients with moyamoya disease. AJNR Am J Neuroradiol 41:2243-2249, 2020

 

5) Funaki T, Miyakoshi A, Kataoka H et al:Larger posterior revascularization associated with reduction of choroidal anastomosis in moyamoya disease:a quantitative angiographic analysis. AJNR Am J Neuroradiol 43:1279-1285, 2022

 

6) 日本脳卒中学会脳卒中ガイドライン委員会編:脳卒中治療ガイドライン2021〔改訂2023〕. pp219-220, 協和企画, 2023

 

7) Yanagihara W, Chida K, Kobayashi M et al:Impact of cerebral blood flow changes due to arterial bypass surgery on cognitive function in adult patients with symptomatic ischemic moyamoya disease. J Neurosurg 131:1716-1724, 2018

 

8) Uchida S, Kubo Y, Oomori D et al:Longterm cognitive changes after revascularization surgery in adult patients with ischemic moyamoya disease. Cerebrovasc Dis Extra 11:145-154, 2021

 

P.69 掲載の参考文献

9) Katakura Y, Kubo Y, Dobashi K et al:Delayed development of cerebral atrophy after cerebral hyperperfusion following arterial bypass for adult patients with ischemic moyamoya disease:supplementary analysis of a 5-year prospective cohort. Acta Neurochir (Wien) 164:1037-1045, 2022

 

10) Kimura K, Kubo Y, Dobashi K et al:Angiographic, cerebral hemodynamic, and cognitive outcomes of indirect revascularization surgery alone for adult patients with misery perfusion due to ischemic moyamoya disease. Neurosurgery 90:676-683, 2022

 

11) Mineharu Y, Takagi Y, Koizumi A et al:Genetic and nongenetic factors for contralateral progression of unilateral moyamoya disease:the first report from the SUPRA Japan Study Group. J Neurosurg 136:1005-1014, 2021

 

P.70 掲載の参考文献

12) Kaku Y, Ohmori Y, Kameno K et al:Inhalational anesthesia reduced transient neurological events after revascularization surgery for moyamoya disease. Neurosurgery, 2023. doi:10.1227/neu.0000000000002804

 

13) Hamano E, Kataoka H, Morita N et al:Clinical implications of the cortical hyperintensity belt sign in fluid-attenuated inversion recovery images after bypass surgery for moyamoya disease. J Neurosurg 126:1-7, 2017

 

14) Takemoto Y, Kawano T, Ohmori Y et al:Hemodynamic study about cortical hyperintensity belt sign after direct bypass surgery for moyamoya disease. J Clin Neurosci 74:124-129, 2020

 

P.71 掲載の参考文献

1) Kim J, Kim BM, Park KY et al:Angioarchitectural analysis of arteriovenous shunts in dural arteriovenous fistulas and its clinical implications. Neurosurgery 91:782-789, 2022

 

P.72 掲載の参考文献

2) Ubbink SWJ, van Dijk JMC, Hofman R et al:Performance of ear canal sound measurements in detecting dural arteriovenous fistulas. J Neurosurg, 2023. doi:10.3171/2023.10.JNS231255

 

3) Li X, Xu N, Meng X et al:Dual-phase contrast-enhanced CT evaluation of dural arteriovenous fistula in patients with pulsatile tinnitus as an initial symptom. Eur J Radiol 148:110137, 2022

 

4) Liang AS, Bounajem MT, Shoskes A et al:Dural arteriovenous fistula in the setting of cerebral venous sinus thrombosis and COVID-19 infection. Neurosurg Focus 56:E17, 2024

 

P.73 掲載の参考文献

5) Garcia-Garcia S, Cepeda S, Arrese I et al:Brain dural arteriovenous fistulas in the COVID-19 era:a warning and rationale for association. Clin Neurol Neurosurg 220:107367, 2022

 

6) Gerasimenko A, Mignot C, Naggara O et al:Cerebral dural arteriovenous fistulas in patients with PTEN-related hamartoma tumor syndrome. Clin Genet, 2024. doi:10.1111/cge.14515

 

7) Wang Y, Ma Y, Yang C et al:Potential biomarkers of spinal dural arteriovenous fistula:C4BPA and C1QA. J Neuroinflammation 19:165, 2022

 

P.74 掲載の参考文献

8) Sanchez S, Raghuram A, Wendt L et al:Natural history, angiographic presentation and outcomes of anterior cranial fossa dural arteriovenous fistulas. J Neurointerv Surg 15:903-908, 2023

 

9) Trivelato FP, Smajda S, Saleme S et al:Endovascular treatment of anterior cranial base dural arteriovenous fistulas as a first-line approach:a multicenter study. J Neurosurg 137:1758-1765, 2022

 

10) Berke CN, Naik A, Majmundar N et al:Microsurgical versus endovascular treatment of ethmoidal dural arteriovenous fistulas:systematic review and meta-analysis with a single-center case series. Neurosurg Focus 56:E15, 2024

 

P.75 掲載の参考文献

11) Xiao Z, Gao W, Zhou H et al:Clinical features, angio-architectural phenotypes, and treatment strategy of foramen magnum dural arteriovenous fistulas:a retrospective case series study. Front Neurol 14:1121075, 2023

 

12) Howard BM, Manupipatpong S, Dion JE et al:Classification and management considerations for intraosseous dural arteriovenous fistulae. Neurosurgery 93:387-398, 2023

 

P.76 掲載の参考文献

13) Schartz D, Rahmani R, Gunthri A et al:Observation versus intervention for Borden type I intracranial dural arteriovenous fistula:a pooled analysis of 469 patients. Interv Neuroradiol 30:175-182, 2024

 

14) Walker E, Srienc A, Lew D et al:Dural arteriovenous fistulas are not observed to convert to a higher grade after partial embolization. Neurosurg Focus 56:E8, 2024

 

15) Cheng HC, Bodani VP, Chung E et al:Transvenous retrograde pressure cooker technique for embolization of an ethmoidal dural arteriovenous fistula. J Neurointerv Surg, 2023. doi:10.1136/jnis-2023-020393

 

16) Devarajan A, Rossitto CP, Al-Kawaz M et al:Transvenous balloon-assisted approach to anterior fossa dural arteriovenous fistula using retrograde pressure cooker technique. J Neurointerv Surg, 2023. doi:10.1136/jnis-2023-020530

 

P.77 掲載の参考文献

17) Sun Z, Wang R, Dong H et al:Prophylactic intra-arterial injection of lidocaine:a novel strategy to prevent endovascular embolization-induced trigeminocardiac reflex. J Neurointerv Surg 15:473-477, 2023

 

18) Guedon A, Elhorany M, Labeyrie MA et al:Transarterial embolization of dural arteriovenous fistulas of the lateral sinuses with stent-assisted sinus protection. J Neurointerv Surg 14:962-967, 2022

 

P.78 掲載の参考文献

19) Muhammad N, Sioutas GS, Gajjar A et al:Intraoperative angiography via popliteal artery access for spinal neurovascular lesions:an institutional experience and systematic review. J Neurointerv Surg 15:787-792, 2023

 

20) Lee YL, Ko CC, Chen CM et al:How I do it:angiography-assisted full endoscopic treatment of spinal dural arteriovenous fistula. Acta Neurochir (Wien) 166:111, 2024

 

21) Singh R, Chen CJ, Didwania P et al:Stereotactic radiosurgery for dural arteriovenous fistulas:a systematic review and meta-analysis and international stereotactic radiosurgery society practice guidelines. Neurosurgery 91:43-58, 2022

 

P.79 掲載の参考文献

22) Kim MJ, Hong SW, Kim DJ et al:Efficacy and safety of stereotactic radiosurgery versus endovascular treatment for symptomatic cavernous sinus dural arteriovenous fistula without ophthalmological emergency:a single-center 10-year experience. J Neurosurg 139:139-149, 2023

 

23) Kim J, Hong SW, Jung HH et al:Stereotactic radiosurgery for noncavernous sinus dural arteriovenous fistulas:treatment outcomes and their predictors. J Neurosurg 140:1389-1398, 2023

 

24) Hasegawa H, Shin M, Kawagishi J et al:A practical grading scale for predicting outcomes of radiosurgery for dural arteriovenous fistulas:JLGK 1802 study. J Stroke 24:278-287, 2022

 

P.80 掲載の参考文献

25) Shinya Y, Hasegawa H, Kawashima M et al:Prognosis of rotational angiography-based stereotactic radiosurgery for dural arteriovenous fistulas:a retrospective analysis. Neurosurgery 92:167-178, 2023

 

P.82 掲載の参考文献

1) RESCUE BT Trial Investigators;Shuai J, Gong Z, Sang H et al:Effect of intravenous tirofiban vs placebo before endovascular thrombectomy on functional outcomes in large vessel occlusion stroke:the RESCUE BT randomized clinical trial. JAMA 328:543-553, 2022

 

2) Alexander H, Claus CF, Tong D et al:Safety and functional outcomes of early antiplatelet therapy within 24 hours following mechanical thrombectomy for secondary prevention in emergent largevessel occlusion strokes:a registry study. Neurosurg Focus 55:E19, 2023

 

3) Chen HS, Cui Y, Zhou ZH et al:Dual antiplatelet therapy vs alteplase for patients with minor nondisabling acute ischemic stroke:the ARAMIS randomized clinical trial. JAMA 329:2135-2144, 2023

 

P.83 掲載の参考文献

4) 日本脳卒中学会脳卒中ガイドライン委員会編:脳卒中治療ガイドライン2021〔改訂2023〕. 協和企画, 2023

 

5) Gao Y, Chen W, Pan Y et al:Dual antiplatelet treatment up to 72 hours after ischemic stroke. N Engl J Med 389:2413-2424, 2023

 

6) Yan Y, Hao R, Zhao X et al:Relationship between CYP2C19*2, *3 gene polymorphism and the recurrence in ischemic stroke patients treated with clopidogrel in China:a meta-analysis. J Stroke Cerebrovasc Dis 31:106798, 2022

 

7) Qiu X, Zhang Y, Gu H et al:Association between CYP2B6 polymorphisms and efficacy of clopidogrel in minor stroke or transient ischemic attack. Stroke 54:1770-1776, 2023

 

P.84 掲載の参考文献

8) Meng X, Wang A, Tian X et al:One-year outcomes of early therapy with ticagrelor vs clopidogrel in CYP2C19 loss-of-function carriers with stroke or TIA trial. Neurology 102:e207809, 2024

 

9) Wang A, Meng X, Tian X et al:Bleeding risk of dual antiplatelet therapy after minor stroke or transient ischemic attack. Ann Neurol 91:380-388, 2022

 

10) Xie X, Johnston SC, Wang A et al:Association of CYP2C19 loss-of-function metabolizer status with stroke risk among Chinese patients treated with ticagreloraspirin vs clopidogrel-aspirin:a prespecified secondary analysis of a randomized clinical trial. JAMA Netw Open 6:e2317037, 2023

 

11) Wang A, Xie X, Tian X et al:Ticagrelor-aspirin versus clopidogrel-aspirin among CYP2C19 loss-of-function carriers with minor stroke or transient ischemic attack in relation to renal function:a post hoc analysis of the CHANCE-2 trial. Ann Intern Med 175:1534-1542, 2022

 

12) Zhang J, Wang A, Tian X et al:Impact of body mass index on efficacy and safety of ticagrelor versus clopidogrel in patients with minor stroke or transient ischemic attack. CMAJ 195:E897-E904, 2023

 

13) Xie X, Jing J, Meng X et al:Dual antiplatelet therapies and causes in minor stroke or transient ischemic attack:a prespecified analysis in the CHANCE-2 trial. Stroke 54:2241-2250, 2023

 

14) Liu H, Jing J, Wang A et al:Stroke recurrence and antiplatelets in posterior versus anterior circulation minor stroke or transient ischemic attack. Stroke 54:964-972, 2023

 

15) Liu H, Jing J, Wang A et al:Genotypeguided dual antiplatelet therapy in minor stroke or transient ischemic attack with a single small subcortical infarction. Neurology 100:e1643-e1654, 2023

 

16) Lun R, Dhaliwal S, Zitikyte G et al:Comparison of ticagrelor vs clopidogrel in addition to aspirin in patients with minor ischemic stroke and transient ischemic attack. JAMA Neurol 79:141-148, 2022

 

17) Ma X, Li D, Liu S et al:Efficacy and safety of ticagrelor versus aspirin and clopidogrel for stroke prevention in patients with vascular disease:a systematic review and meta-analysis. Eur Neurol 86:229-241, 2023

 

P.85 掲載の参考文献

18) Aref HM, El-Khawas H, Elbassiouny A et al:A randomized pilot study of the efficacy and safety of loading ticagrelor in acute ischemic stroke. Neurol Sci 44:765-771, 2023

 

19) Zi W, Song J, Kong W et al:Tirofiban for stroke without large or medium-sized vessel occlusion. N Engl J Med 388:2025-2036, 2023

 

20) Pan Y, Meng X, Yuan B et al:Indobufen versus aspirin in patients with acute ischaemic stroke in China (INSURE):a randomised, double-blind, double-dummy, active control, non-inferiority trial. Lancet Neurol 22:485-493, 2023

 

P.86 掲載の参考文献

21) Liu X, Lv X, Peng Y et al:Clopidogrel with indobufen or aspirin in minor ischemic stroke or high-risk transient ischemic attack:a randomized controlled clinical study. BMC Neurol 24:81, 2024

 

22) Nishiyama Y, Kimura K, Otsuka T et al:Dual antiplatelet therapy with cilostazol for secondary prevention in lacunar stroke:subanalysis of the CSPS.com trial. Stroke 54:697-705, 2023

 

23) Toyoda K, Omae K, Hoshino H et al:Association of timing for starting dual antiplatelet treatment with cilostazol and recurrent stroke. Neurology 98:e983-e992, 2022

 

24) Uchiyama S, Toyoda K, Okamura S et al:Dual antiplatelet therapy with cilostazol in stroke patients with extracranial arterial stenosis or without arterial stenosis:a subgroup analysis of the CSPS.com trial. Int J Stroke 18:426-432, 2022

 

P.87 掲載の参考文献

25) Hoshino H, Toyoda K, Omae K et al:Sex difference in the impact of dual antiplatelet therapy using cilostazol for secondary stroke prevention:a sub-analysis of CSPS.com. J Atheroscler Thromb 30:675-683, 2023

 

26) Tornyos D, Komocsi A, Balint A et al:Antithrombotic therapy for secondary prevention in patients with stroke or transient ischemic attack:a multiple treatment network meta-analysis of randomized controlled trials. PLoS ONE 17:e0273103, 2022

 

27) Hou X, Cen K, Cui Y et al:Antiplatelet therapy for secondary prevention of lacunar stroke:a systematic review and network meta-analysis. Eur J Clin Pharmacol 79:63-70, 2023

 

28) Kitazono T, Kamouchi M, Matsumaru Y et al:Efficacy and safety of prasugrel vs clopidogrel in thrombotic stroke patients with risk factors for ischemic stroke recurrence:a double-blind, phaseIII study (PRASTRO-III). J Atheroscler Thromb 30:222-236, 2023

 

29) Kitazono T, Kamouchi M, Matsumaru Y et al:Comparison of prasugrel and clopidogrel in thrombotic stroke patients with risk factors for ischemic stroke recurrence:an integrated analysis of PRASTRO-I, PRASTRO-II, and PRASTRO-III. Cerebrovasc Dis 52:720-729, 2023

 

P.88 掲載の参考文献

30) Cloud GC, Williamson JD, Thao LTP et al:Low-dose aspirin and the risk of stroke and intracerebral bleeding in healthy older people:secondary analysis of a randomized clinical trial. JAMA Netw Open 6:e2325803, 2023

 

P.89 掲載の参考文献

1) Lip GYH, Proietti M, Potpara T et al:Atrial fibrillation and stroke prevention:25 years of research at EP Europace journal. Europace 25:euad226, 2023

 

2) Linz D, Gawalko M, Betz K et al:Atrial fibrillation:epidemiology, screening and digital health. Lancet Reg Health Eur 37:1007786, 2024

 

P.90 掲載の参考文献

3) Akao M, Ogawa H, Masunaga N et al;Fushimi AF Registry Investigators:10-year trends of antithrombotic therapy status and outcomes in Japanese atrial fibrillation patients - the Fushimi AF Registry. Circ J 86:726-736, 2022

 

4) Fischer U, Koga M, Strbian D et al;ELAN Investigators:Early versus later anticoagulation for stroke with atrial fibrillation. N Engl J Med 388:2411-2421, 2023

 

5) Ma H, Che R, Zhang Q et al:The optimum anticoagulation time after endovascular thrombectomy for atrial fibrillation-related large vessel occlusion stroke:a real-world study. J Neurol 270:2084-2095, 2023

 

P.91 掲載の参考文献

6) Ip YMB, Lau KK, Ko H et al:Association of alternative anticoagulation strategies and outcomes in patients with ischemic stroke while taking a direct oral anticoagulant. Neurology 101:e358-e369, 2023

 

7) RAF and RENO-EXTEND Investigators:Risk of recurrent stroke in patients with atrial fibrillation treated with oral anticoagulants alone or in combination with antiplatelet therapy. Eur Stroke J 8:722-730, 2023

 

8) Chao TF, Potpara TS, Lip GYH:Atrial fibrillation:stroke prevention. Lancet Reg Health Eur 37:100797, 2024

 

9) Chao TF, Tse HF, Teo WS et al;Asia Pacific Heart Rhythm Society Atrial Fibrillation Registry Investigators:Clinical utility and prognostic implications of the 4S-AF scheme:report from Asia Pacific Heart Rhythm Society Atrial Fibrillation Registry. Eur J Clin Invest 52:e13825, 2022

 

P.92 掲載の参考文献

10) Jensen M, Suling A, Metzner A et al:Early rhythm-control therapy for atrial fibrillation in patients with a history of stroke:a subgroup analysis of the EAST-AFNET 4 trial. Lancet Neurol 22:45-54, 2023

 

11) Chao TF, Unverdorben M, Kirchhof P et al:Prescribing patterns and outcomes of edoxaban in atrial fibrillation:one-year data from the Global ETNA-AF program. J Clin Med 12:1870, 2023

 

12) Caso V, de Groot JR, Sanmartin Fernandez M et al:Outcomes and drivers of inappropriate dosing of non-vitamin K antagonist oral anticoagulants (NOACs) in patients with atrial fibrillation:a systematic review and meta-analysis. Heart 109:178-185, 2023

 

13) Sakai K, Suda S, Iguchi Y et al:High prestroke CHADS2 score predicts unfavorable functional outcome in acute cardioembolic stroke patients prescribed oral anticoagulant therapy:a sub-analysis of the PASTA registry study. J Stroke Cerebrovasc Dis 33:107519, 2024

 

14) Yoshimoto T, Toyoda K, Ihara M et al:Impact of previous stroke on clinical outcome in elderly patients with nonvalvular atrial fibrillation:ANAFIE registry. Stroke 53:2549-2558, 2022

 

P.93 掲載の参考文献

15) Kumar V, Ilkhanoff L:Anticoagulants for atrial fibrillation:from warfarin and DOACs to the promise of factor XI inhibitors. Front Cardiovasc Med 11:1352734, 2024

 

16) Savage P, Cox B, Shahmohammadi M et al:Advances in clinical cardiology 2023:a summary of key clinical Trials. AdvTher, 2024. doi:10.1007/s12325-024-02877-y

 

17) Osmancik P, Herman D, Neuzil P et al;PRAGUE-17 Trial Investigators:4-year outcomes after left atrial appendage closure versus nonwarfarin oral anticoagulation for atrial fibrillation. J Am Coll Cardiol 79:1-14, 2022

 

P.94 掲載の参考文献

18) Dai WL, Zhao ZX, Jiang C et al:Catheter ablation versus medical therapy for atrial fibrillation with prior stroke history:a prospective propensity score-matched cohort study. J Geriatr Cardiol 20:707-715, 2023

 

19) Kanaoka K, Nishida T, Iwanaga Y et al:Oral anticoagulation after atrial fibrillation catheter ablation:benefits and risks. Eur Heart J 45:522-534, 2024

 

20) Nogami A, Soejima K, Morishima I et al;RYOUMA Investigators:Real-world investigation on anticoagulation management before and after catheter ablation for atrial fibrillation in Japan - periprocedural and long-term outcomes. Circ J 87:50-62, 2022

 

21) Milling TJ Jr, Middeldorp S, Xu L et al;ANNEXA-4 Investigators:Final study report of andexanet alfa for major bleeding with factor Xa inhibitors. Circulation 147:1026-1038, 2023

 

P.95 掲載の参考文献

22) Rahman AA, Platt RW, Beradid S et al:Concomitant use of selective serotonin reuptake inhibitors with oral anticoagulants and risk of major bleeding. JAMA Netw Open 7:e243208, 2024

 

23) Wagner B, Hert L, Polymeris AA et al:Impact of type of oral anticoagulants in patients with cerebral microbleeds after atrial fibrillation-related ischemic stroke or TIA:results of the NOACISP-LONG-TERM registry. Front Neurol 13:964723, 2022

 

P.96 掲載の参考文献

24) Masunaga N, Ogawa H, Minami K et al;Fushimi AF Registry Investigators:Association of concomitant coronary artery disease with cardiovascular events in patients with atrial fibrillation - the Fushimi AF Registry. Circ J 86:1252-1262, 2022

 

25) Pardo-Galiana B, Medina-Rodriguez M, Millan-Vazquez M et al:Antithrombotic treatment after carotid stenting in patients with concomitant atrial fibrillation. AJNR Am J Neuroradiol 43:727-730, 2022

 

P.97 掲載の参考文献

26) Al-Shahi Salman R, Stephen J, Tierney JF et al;Collaboration of Controlled Randomised Trials of Long-Term Oral Antithrombotic Agents After Spontaneous Intracranial Haemorrhage (COCROACH):Effects of oral anticoagulation in people with atrial fibrillation after spontaneous intracranial haemorrhage (COCROACH):prospective, individual participant data meta-analysis of randomised trials. Lancet Neurol 22:1140-1149, 2023

 

P.98 掲載の参考文献

1) Dusenbury W, Mathiesen C, Whaley M et al:Ideal foundational requirements for stroke program development and growth:a scientific statement from the American Heart Association. Stroke 54:e175-e187, 2023

 

P.99 掲載の参考文献

2) Raychev R, Sun JL, Schwamm L et al:Performance of thrombectomy-capable, comprehensive, and primary stroke centers in reperfusion therapies for acute ischemic stroke:report from the Get With The Guidelines-Stroke registry. Circulation 148:2019-2028, 2023

 

3) Ren N, Ogata S, Kiyoshige E et al:Associations between adherence to evidence-based, stroke quality indicators and outcomes of acute reperfusion therapy. Stroke 53:3359-3368, 2022

 

P.100 掲載の参考文献

4) Zheng S, Zhang T, Gu HQ et al:Adherence to stroke care performance measures in different regions in China, 2015-2019:evidence from the Chinese Stroke Center Alliance. Neurology 99:e1767-e1778, 2022

 

5) Asif KS, Otite FO, Desai SM et al:Mechanical Thrombectomy Global Access For Stroke (MT-GLASS):a mission thrombectomy (MT-2020 Plus) study. Circulation 147:1208-1220, 2023

 

6) Feldmeier M, Kim AS, Zachrison KS et al:Heterogeneity of state stroke center certification and designation processes. Stroke 55:1051-1058, 2024

 

P.101 掲載の参考文献

7) van Stigt MN, Groenendijk EA, van Meenen LCC et al:Prehospital detection of large vessel occlusion stroke with EEG. Neurology 101:e2522-e2532, 2023

 

8) Perez de la Ossa N, Abilleira S, Jovin TG et al:Effect of direct transportation to thrombectomy-capable center vs local stroke center on neurological outcomes in patients with suspected large-vessel occlusion stroke in nonurban areas:the RACECAT randomized clinical trial. JAMA 327:1782-1794, 2022

 

9) Ramos-Pachon A, Rodriguez-Luna D, Marti-Fabregas J et al:Effect of bypassing the closest stroke center in patients with intracerebral hemorrhage:a secondary analysis of the RACECAT randomized clinical trial. JAMA Neurol 80:1028-1036, 2023

 

P.102 掲載の参考文献

10) Katsanos AH, Sarraj A, Froehler M et al:IV thrombolysis initiated before transfer for endovascular stroke thrombectomy:a systematic review and meta-analysis. Neurology 100:e1436-e1443, 2023

 

11) Hubert GJ, Hubert ND, Maegerlein C et al:Association between use of a flying intervention team vs patient interhospital transfer and time to endovascular thrombectomy among patients with acute ischemic stroke in nonurban Germany. JAMA 327:1795-1805, 2022

 

P.103 掲載の参考文献

12) Garcia-Esperon C, Wu TY, Carraro do Nascimento V et al:Ultra-long transfers for endovascular thrombectomy-mission impossible?:the Australia-New Zealand experience. Stroke 54:151-158, 2023

 

13) Sarraj A, Hill MD, Hussain MS et al:Endovascular thrombectomy treatment effect in direct vs transferred patients with large ischemic strokes:a prespecified analysis of the SELECT2 trial. JAMA Neurol 81:327-335, 2024

 

14) Liu Z, Yang K, Gu H et al:Impact of offhour admission on in-hospital outcomes for patients with stroke receiving reperfusion therapy in China. Stroke 55:1359-1369, 2024

 

15) Seker F, Fifi JT, Morey JR et al:Transferring neurointerventionalists saves time compared with interhospital transfer of stroke patients for endovascular thrombectomy:a collaborative pooled analysis of 1001 patients (EVEREST). J Neurointerv Surg 15:517-520, 2023

 

P.104 掲載の参考文献

16) Elijovich L, Dornbos Iii D, Nickele C et al:Automated emergent large vessel occlusion detection by artificial intelligence improves stroke workflow in a hub and spoke stroke system of care. J Neurointerv Surg 14:704-708, 2022

 

17) Al-Kawaz M, Primiani C, Urrutia V et al:Impact of RapidAI mobile application on treatment times in patients with large vessel occlusion. J Neurointerv Surg 14:233-236, 2022

 

18) Ho W, Fawcett AP:Outcomes in patients with acute stroke treated at a comprehensive stroke center using telemedicine versus in-person assessments. J Telemed Telecare, 2023. doi:10.1177/1357633X231169115

 

19) Lyerly MJ, Daggy J, LaPradd M et al:Impact of telestroke implementation on emergency department transfer rate. Neurology 98:e1617-e1625, 2022

 

20) Sanmartin MX, Katz JM, Eusemann C et al:Cost-effectiveness of remote robotic mechanical thrombectomy in acute ischemic stroke. J Neurosurg 139:721-731, 2023

 

P.105 掲載の参考文献

1) Nguyen TN, Castonguay AC, Siegler JE et al:Mechanical thrombectomy in the late presentation of anterior circulation large vessel occlusion stroke:a guideline from the Society of Vascular and Interventional Neurology Guidelines and Practice Standards Committee. Stroke Vasc Interv Neurol 3:e000512, 2023

 

2) Olthuis SGH, Pirson FAV, Pinckaers FME et al:Endovascular treatment versus no endovascular treatment after 6-24 h in patients with ischaemic stroke and collateral flow on CT angiography (MR CLEANLATE) in the Netherlands:a multicentre, open-label, blinded-endpoint, randomised, controlled, phase 3 trial. Lancet 401:1371-1380, 2023

 

P.106 掲載の参考文献

3) Huo X, Ma G, Tong X et al:Trial of endovascular therapy for acute ischemic stroke with large infarct. N Engl J Med 388:1272-1283, 2023

 

4) Sarraj A, Hassan AE, Abraham MG et al:Trial of endovascular thrombectomy for large ischemic strokes. N Engl J Med 388:1259-1271, 2023

 

5) Bendszus M, Fiehler J, Subtil F et al:Endovascular thrombectomy for acute ischaemic stroke with established large infarct:multicentre, open-label, randomised trial. Lancet 402:1753-1763, 2023

 

6) Sarraj A, Abraham MG, Hassan AE et al:Endovascular thrombectomy plus medical care versus medical care alone for large ischaemic stroke:1-year outcomes of the SELECT2 trial. Lancet 403:731-740, 2024

 

7) 日本脳卒中学会脳卒中ガイドライン委員会編:脳卒中治療ガイドライン2021〔改訂2023〕. 協和企画, 2023

 

8) 日本脳卒中学会, 日本脳神経外科学会, 日本脳神経血管内治療学会:経皮経管的脳血栓回収用機器適正使用指針第5版2023年8月. 脳卒中 46:181-216, 2024

 

9) Tao C, Nogueira RG, Zhu Y et al:Trial of endovascular treatment of acute basilarartery occlusion. N Engl J Med 387:1361-1372, 2022

 

10) Jovin TG, Li C, Wu L et al:Trial of thrombectomy 6 to 24 hours after stroke due to basilar-artery occlusion. N Engl J Med 387:1373-1384, 2022

 

11) Fischer U, Kaesmacher J, Strbian D et al;SWIFT DIRECT Collaborators:Thrombectomy alone versus intravenous alteplase plus thrombectomy in patients with stroke:an open-label, blinded-outcome, randomised non-inferiority trial. Lancet 400:104-115, 2022

 

12) Mitchell PJ, Yan B, Churilov L et al:Endovascular thrombectomy versus standard bridging thrombolytic with endovascular thrombectomy within 4.5 h of stroke onset:an open-label, blinded-endpoint, randomised non-inferiority trial. Lancet 400:116-125, 2022

 

13) Majoie CB, Cavalcante F, Gralla J et al;IRIS collaborators:Value of intravenous thrombolysis in endovascular treatment for large-vessel anterior circulation stroke:individual participant data meta-analysis of six randomised trials. Lancet 402:965-974, 2023

 

P.107 掲載の参考文献

14) Turc G, Tsivgoulis G, Audebert HJ et al:European Stroke Organisation (ESO) -European Society for Minimally Invasive Neurological Therapy (ESMINT) expedited recommendation on indication for intravenous thrombolysis before mechanical thrombectomy in patients with acute ischemic stroke and anterior circulation large vessel occlusion. J Neurointervent Surg 14:209-227, 2022

 

15) Kaesmacher J, Cavalcante F, Kappelhof M et al:Time to treatment with intravenous thrombolysis before thrombectomy and functional outcomes in acute ischemic stroke:a meta-analysis. JAMA 331:764-777, 2024

 

16) Albers GW, Jumaa M, Purdon B et al:Tenecteplase for stroke at 4.5 to 24 hours with perfusion-imaging selection. N Engl J Med 390:701-711, 2024

 

17) RESCUE BT Trial Investigators;Qiu Z, Li F, Sang H et al:Effect of intravenous tirofiban vs placebo before endovascular thrombectomy on functional outcomes in large vessel occlusion stroke:the RESCUE BT randomized clinical trial. JAMA 328:543-553, 2022

 

18) Hong JM, Lee JS, Lee YB et al:Nelonemdaz for patients with acute ischemic stroke undergoing endovascular reperfusion therapy:a randomized phase II trial. Stroke 53:3250-3259, 2022

 

19) Hernandez-Jimenez M, Abad-Santos F, Cotgreave I et al:Safety and efficacy of ApTOLL in patients with ischemic stroke undergoing endovascular treatment:a phase 1/2 randomized clinical trial. JAMA Neurol 80:779-788, 2023

 

P.108 掲載の参考文献

20) MARVEL Trial Authors for the MARVEL Investigators;Yang Q, Guo C, Yue C et al:Methylprednisolone as adjunct to endovascular thrombectomy for large-vessel occlusion stroke:the MARVEL randomized clinical trial. JAMA 331:840-849, 2024

 

21) Maurice A, Eugene F, Ronziere T et al;GASS (General Anesthesia versus Sedation for Acute Stroke Treatment) Study Group and the French Society of Anesthesiologists (SFAR) Research Network:General anesthesia versus sedation, both with hemodynamic control, during intraarterial treatment for stroke:the GASS randomized trial. Anesthesiology 136:567-576, 2022

 

22) Chabanne R, Geeraerts T, Begard M et al:Outcomes after endovascular therapy with procedural sedation vs general anesthesia in patients with acute ischemic stroke:the AMETIS randomized clinical trial. JAMA Neurol 80:474-483, 2023

 

23) Liang F, Wu Y, Wang X et al;CANVAS II Group:General anesthesia vs conscious sedation for endovascular treatment in patients with posterior circulation acute ischemic stroke:an exploratory randomized clinical trial. JAMA Neurol 80:64-72, 2023

 

24) Yang P, Song L, Zhang Y et al;ENCHANTED2/MT Investigators:Intensive blood pressure control after endovascular thrombectomy for acute ischaemic stroke (ENCHANTED2/MT):a multicentre, open-label, blinded-endpoint, randomised controlled trial. Lancet 400:1585-1596, 2022

 

25) Mistry EA, Hart KW, Davis LT et al:Blood pressure management after endovascular therapy for acute ischemic stroke:the BEST-II randomized clinical trial. JAMA 330:821-831, 2023

 

P.109 掲載の参考文献

26) Nam HS, Kim YD, Heo J et al;OPTIMAL-BP Trial Investigators:Intensive vs conventional blood pressure lowering after endovascular thrombectomy in acute ischemic stroke:the OPTIMAL-BP randomized clinical trial. JAMA 330:832-842, 2023

 

27) Gharaibeh K, Aladamat N, Mierzwa AT et al:Blood pressure after successful endovascular therapy:a systematic review and meta-analysis of randomized control trials. Ann Neurol 95:858-865, 2024

 

28) Perez de la Ossa N, Abilleira S, Jovin TGet al;RACECAT Trial Investigators:Effect of direct transportation to thrombectomy-capable center vs local stroke center on neurological outcomes in patients with suspected large-vessel occlusion stroke in nonurban areas:the RACECAT randomized clinical trial. JAMA 327:1782-1794, 2022

 

29) Behrndtz A, Blauenfeldt RA, Johnsen SP et al:Transport strategy in patients with suspected acute large vessel occlusion stroke:TRIAGE-STROKE, a randomized clinical trial. Stroke 54:2714-2723, 2023

 

30) Nogueira RG, Lobsien D, Klisch J et al:Thrombectomy with the pRESET vs Solitaire stent retrievers as first-line large vessel occlusion stroke treatment:a randomized clinical trial. JAMA Neurol 81:170-178, 2024

 

P.112 掲載の参考文献

1) Dmytriw AA, Dibas M, Ghozy S et al:The Woven EndoBridge (WEB) device for the treatment of intracranial aneurysms:ten years of lessons learned and adjustments in practice from the World-WideWEB consortium. Transl Stroke Res 14:455-464, 2023

 

2) Semeraro V, Palmisano V, Limbucci N et al:Woven EndoBridge device for unruptured wide-neck bifurcation aneurysm:a multicenter 5-year follow-up. Neurosurgery 94:1044-1050, 2024

 

3) Fiorella D, Molyneux A, Coon A et al:Safety and effectiveness of the Woven EndoBridge (WEB) system for the treatment of wide necked bifurcation aneurysms:final 5 year results of the pivotal WEB Intra-saccular Therapy study (WEBIT). J NeuroInterv Surg 15:1175-1180, 2023

 

P.113 掲載の参考文献

4) Rodriguez-Calienes A, Vivanco-Suarez J, Lu Y et al:Woven EndoBridge versus stentassisted coil embolization for the treatment of ruptured wide-necked aneurysms:a multicentric experience. Interv Neuroradiol, 2024. doi:10.1177/15910199231223538

 

5) Salem MM, Jankowitz BT, Burkhardt JK et al:Comparative analysis of long term effectiveness of Neuroform Atlas stent versus low profile visualized intraluminal stent/Woven EndoBridge devices in treatment of wide necked intracranial aneurysms. J Neurointerv Surg, 2023. doi:10.1136/jnis-2023-020716

 

6) Signorovitch JE, Sikirica V, Erder MH et al:Matching-adjusted indirect comparisons:a new tool for timely comparative effectiveness research. Value Health 15:940-947, 2012

 

P.114 掲載の参考文献

7) Gallo-Pineda F, Fernandez-Gomez M, Dominguez-Rodriguez C et al:Evaluating efficacy and complications of contour intrasaccular device in cerebral aneurysm management:a multicenter analysis. World Neurosurg 183:e738-e746, 2024

 

8) Mostafa K, Neves FB, Gartner F et al:Contour device implantation versus coil embolization for treatment of narrow neck intracranial aneurysms. Sci Rep 13:4904, 2023

 

9) Liebig T, Gal G, O'Kelly C et al:Neqstent coil-assisted flow diverter (NQS) for the treatment of bifurcation aneurysms:the coil-assisted flow diversion safety and performance study (CAFI). J Neurointerv Surg, 2023. doi:10.1136/jnis-2022-020056

 

10) Morales-Caba L, Lylyk I, Vazquez-Anon V et al:The pCONUS2 and pCONUS2 HPC neck bridging devices:results from an international multicenter retrospective study. Clin Neuroradiol 33:129-136, 2023

 

P.115 掲載の参考文献

11) Lim J, Monteiro A, Jacoby WT et al:Coiling variations for treatment of ruptured intracranial aneurysms:a meta-analytical comparison of comaneci-, stent-, and balloon-coiling assistance techniques. World Neurosurg 175:e1324-e1340, 2023

 

P.116 掲載の参考文献

1) Shehata MA, Ibrahim MK, Ghozy S et al:Long-term outcomes of flow diversion for unruptured intracranial aneurysms:a systematic review and meta-analysis. J Neurointerv Surg 15:898-902, 2023

 

2) Salem MM, Sweid A, Kuhn AL et al:Repeat flow diversion for cerebral aneurysms failing prior flow diversion:safety and feasibility from multicenter experience. Stroke 53:1178-1189, 2022

 

P.117 掲載の参考文献

3) Gui S, Chen X, Wei D et al:Long-term outcomes and dynamic changes of in-stent stenosis after Pipeline embolization device treatment of intracranial aneurysms. J Neurointerv Surg 15:1187-1193, 2023

 

4) Li S, Zeng C, Tao W et al:The safety and efficacy of flow diversion versus conventional endovascular treatment for intracranial aneurysms:a meta-analysis of real-world cohort studies from the past 10 years. AJNR Am J Neuroradiol 43:1004-1011, 2022

 

5) Cler SJ, Lauzier DC, Chatterjee AR et al:Comparative study of on-label versus off-label treatment of intracranial aneurysms with the Pipeline embolization device. J Neurosurg 137:685-690, 2022

 

6) Wang J, Deng X, Li D et al:Pipeline embolization of complex, wide-necked middle cerebral artery bifurcation aneurysms:a single-center experience. Interv Neuroradiol 30:227-233, 2024

 

7) Lee J, Kim DH, Lee SH et al:Stent-assisted coiling vs. flow diverter for treating blood blister-like aneurysms:a proportion meta-analysis. Clin Neuroradiol 32:889-902, 2022

 

8) Srinivasan VM, Jubran JH, Stonnington HO et al:Flow diversion for basilar quadrifurcation aneurysms. J Neurointerv Surg 16:372-378, 2024

 

P.118 掲載の参考文献

9) Chia GS, de Villiers L, Carraro do Nascimento V et al:Safety and clinical effectiveness of Pipeline Shield Device for intracranial aneurysms in an Australian cohort (SCOPE-AUS). Stroke Vasc Neurol 2:e000292, 2022

 

10) Cortez GM, Benalia VHC, Sauvageau E et al:Diffusion-weighted imaging lesions after intracranial aneurysm treatment with Pipeline Flex and Pipeline Flex with Shield technology:a retrospective cohort analysis. J Neurointerv Surg 16:385-391, 2024

 

11) Vollherbst DF, Lucking H, DuPlessis J et al:The FRESH study:treatment of intracranial aneurysms with the New FRED X flow diverter with antithrombotic surface treatment technology-first multicenter experience in 161 patients. AJNR Am J Neuroradiol 44:474-480, 2023

 

12) Sciacca S, Bassiouny A, Mansoor N et al:Early outcomes of the Pipeline Vantage flow diverter:a multicentre study. Clin Neuroradiol 33:887-896, 2023

 

13) de Villiers L, Carraro do Nascimento V, Domitrovic L et al:Vanguard Study:initial experience with the new fourth generation Pipeline Vantage Flow Diverter (PVFD):6-month results, technical and clinical considerations. J Neurointerv Surg, 2024. doi:10.1136/jnis-2023-021182

 

P.119 掲載の参考文献

14) Bonafe A, Perez MA, Henkes H et al:Diversion-p64:results from an international, prospective, multicenter, single-arm post-market study to assess the safety and effectiveness of the p64 flow modulation device. J Neurointerv Surg 14:898-903, 2022

 

15) Oliver AA, Bilgin C, Vercnocke AJ et al:Benchtop proof of concept and comparison of iron- and magnesium-based bioresorbable flow diverters. J Neurosurg 139:150-156, 2023

 

16) Sasaki N, Ishii A, Yagi S et al:Bioresorbable poly (L-lactic acid) flow diverter versus cobalt-chromium flow diverter:in vitro and in vivo analysis. Stroke 54:1627-1635, 2023

 

17) Akiyama R, Ishii A, Kikuchi T et al:Onset-to-treatment time and aneurysmal regression predict improvement of cranial neuropathy after flow diversion treatment in patients with symptomatic internal carotid artery aneurysms. J Neurointerv Surg 15:886-891, 2023

 

P.120 掲載の参考文献

18) Kiyofuji S, Graffeo CS, Perry A et al:Meta-analysis of treatment outcomes of posterior circulation non-saccular aneurysms by flow diverters. J Neurointerv Surg 10:493-499, 2018

 

19) Baker CM, Hunsaker JC, Folzenlogen ZA et al:Technical nuances and outcomes of Telescoping pipeline flow diverters:a multicenter study. Oper Neurosurg (Hagerstown) 24:e255-e263, 2023

 

20) Hohenstatt S, Ulfert C, Herweh C et al:Acute intraprocedural thrombosis after flow diverter stent implantation:risk factors and relevance of standard observation time for early detection and management. Clin Neuroradiol 33:343-351, 2023

 

21) El Naamani K, Saad H, Chen CJ et al:Comparison of flow-redirection endoluminal device and pipeline embolization device in the treatment of intracerebral aneurysms. Neurosurgery 92:118-124, 2023

 

22) Matsukawa H, Uchida K, Rajbhandari S et al:Difference in the cumulative incidence of aneurysmal occlusion by Flow Redirection Endoluminal Device and Pipeline Embolization Device in the treatment of unruptured internal carotid artery aneurysms:a propensity score-matched cohort study. Neurosurg Rev 46:125, 2023

 

P.122 掲載の参考文献

1) Li W, Wu C, Deng R et al:Comparison of perioperative safety of carotid artery stenting and endarterectomy in the treatment of carotid artery stenosis:a meta-analysis of randomized controlled trials. World Neurosurg 181:e356-e375, 2024

 

2) Reiff T, Eckstein HH, Mansmann U et al:Carotid endarterectomy or stenting orbest medical treatment alone for moderate-to-severe asymptomatic carotid artery stenosis:5-year results of a multicentre, randomised controlled trial. Lancet Neurol 21:877-888, 2022

 

3) Poorthuis MHF, Solomon Y, Herings RAR et al:Temporal trends and determinants of stroke risk in patients with medically treated asymptomatic carotid stenosis. Stroke 54:1735-1749, 2023

 

4) Kremer C, Lorenzano S, Bejot Y et al:Sex differences in outcome after carotid revascularization in symptomatic and asymptomatic carotid artery stenosis. J VascSurg 78:817-827. e10, 2023

 

5) Larson A, Nardi V, Brinjikji W et al:Endarterectomy for symptomatic non-stenotic carotids:a systematic review and descriptive analysis. Stroke Vasc Neurol 7:6-12, 2022

 

6) Kurosaki Y, Kinosada M, Ikeda H et al:Clinical features and long-term outcomes of symptomatic low-grade carotid stenosis. J Stroke Cerebrovasc Dis 31:106779, 2022

 

P.123 掲載の参考文献

7) Leung YYR, Bera K, Urriza Rodriguez D et al:Safety of carotid endarterectomy for symptomatic stenosis by age:meta-analysis with individual patient data. Stroke 54:457-467, 2023

 

8) Sugiyama T, Ito M, Sugimori H et al:Tissue acceleration as a novel metric for surgical performance during carotid endarterectomy. Oper Neurosurg (Hagerstown) 25:343-352, 2023

 

9) Rychen J, Madarasz A, Murek M et al:Management of postoperative internal carotid artery intimal flap after carotid endarterectomy:a cohort study and systematic review. J Neurosurg 136:647-654, 2022

 

P.124 掲載の参考文献

10) Squizzato F, Piazza M, Forcella E et al:Impact of carotid stent design on embolic filter debris load during carotid artery stenting. Stroke 54:2534-2541, 2023

 

11) Batista S, Oliveira L de B, Sousa MP et al:Transradial artery access for carotid artery stenting:a pooled analysis. Neuroradiol J, 2024. doi:10.1177/19714009231224410

 

12) Zhou C, Cao YZ, Jia ZY et al:Endovascular recanalization of symptomatic chronic ICA occlusion:procedural outcomes and radiologic predictors. AJNR Am J Neuroradiol 44:303-310, 2023

 

13) de Borst GJ:Transcarotid artery revascularization. Br J Surg 110:127-128, 2023

 

14) Stonko DP, Goldsborough E 3rd, Kibrik P et al:Use of transcarotid artery revascularization, transfemoral carotid artery stenting, and carotid endarterectomy in the US from 2015 to 2019. JAMA Netw Open 5:E2231944, 2022

 

P.125 掲載の参考文献

15) Zarrintan S, Elsayed N, Patel RJ et al:Propensity-score matched analysis of three years survival of trans carotid artery revascularization versus carotid endarterectomy in the Vascular Quality Initiative Medicare-Linked database. Ann Surg 278:559-567, 2023

 

16) Naazie IN, Dodo-Williams T, Janssen C et al:Impact of flow reversal duration on neurological outcomes of transcarotid artery revascularization (TCAR). Ann Vasc Surg 89:11-19, 2023

 

17) Mayorga-Carlin M, Shaw P, Ozsvath K et al:Transcarotid revascularization outcomes do not differ by patient age or sex. J Vasc Surg 76:209-219. e2, 2022

 

18) Mehta V, Tharp P, Caruthers C et al:Transcarotid artery revascularization can safely be performed with regional anesthesia and no intensive care unit stay. J VascSurg 77:555-558, 2023

 

19) Farooqui M, Zaidat OO, Hassan AE et al:Functional and safety outcomes of carotid artery stenting and mechanical thrombectomy for large vessel occlusion ischemic stroke with tandem lesions. JAMA Netw Open 6:E230736, 2023

 

20) Diana F, Romoli M, Toccaceli G et al:Emergent carotid stenting versus no stenting for acute ischemic stroke due to tandem occlusion:a meta-analysis. J Neurointerv Surg 15:428-432, 2023

 

21) van Elk T, Maes L, van der Meij A et al:Immediate carotid artery stenting or deferred treatment in patients with tandem carotid lesions treated endovascularly for acute ischaemic stroke. EJVES Vasc Forum 61:31-35, 2024

 

P.126 掲載の参考文献

22) van Dam-Nolen DHK, Truijman MTB, van der Kolk AG et al:Carotid plaque characteristics predict recurrent ischemic stroke and TIA:the PARISK (Plaque At RISK) Study. JACC Cardiovasc Imaging 15:1715-1726, 2022

 

23) Camps-Renom P, McCabe J, Marti-Fabregas J et al:Association of plaque inflammation with stroke recurrence in patients with unproven benefit from carotid revascularization. Neurology 99:e109-e118, 2022

 

24) Zhang R, Zhang Q, Ji A et al:Prediction of new cerebral ischemic lesion after carotid artery stenting:a high-resolution vessel wall MRI-based radiomics analysis. Eur Radiol 33:4115-4126, 2023

 

25) Homssi M, Saha A, Delgado D et al:Extracranial carotid plaque calcification and cerebrovascular ischemia:a systematic review and meta-analysis. Stroke 54:2621-2628, 2023

 

P.127 掲載の参考文献

26) Mota L, Wang SX, Cronenwett JL et al:Association of stroke or death with severity of carotid lesion calcification in patients undergoing carotid artery stenting. J Vasc Surg 79:305-315. e3, 2024

 

27) Marfella R, Prattichizzo F, Sardu C et al:Microplastics and nanoplastics in atheromas and cardiovascular events. N Engl J Med 390:900-910, 2024

 

28) Griffin KJ, Harmsen WS, Mandrekar J et al:Epidemiology of spontaneous cervical artery dissection:population-based study. Stroke 55:670-677, 2024

 

29) Bontinis V, Antonopoulos CN, Bontinis A et al:A systematic review and meta-analysis of carotid artery stenting for the treatment of cervical carotid artery dissection. Eur J Vasc Endovasc Surg 64:299-308, 2022

 

30) Yaghi S, Engelter S, Del Brutto VJ et al:Treatment and outcomes of cervical artery dissection in adults:a scientific statement from the American Heart Association. Stroke 55:e91-e106, 2024

 

P.128 掲載の参考文献

1) Zhai Y, Shi M, Liu Y et al:Magnitude of systolic blood pressure reduction and early achieved blood pressure and clinical outcomes after acute ischemic stroke. J Am Heart Assoc 12:e030692, 2023

 

P.129 掲載の参考文献

2) Liu L, Xie X, Pan Y et al:Early versus delayed antihypertensive treatment in patients with acute ischaemic stroke:multicentre, open label, randomised, controlled trial. BMJ 383:e076448, 2023

 

3) Wang X, Minhas JS, Moullaali TJ et al:Associations of early systolic blood pressure control and outcome after thrombolysis-eligible acute ischemic stroke:results from the ENCHANTED Study. Stroke 53:779-787, 2022

 

P.130 掲載の参考文献

4) Mistry EA, Hart KW, Davis LT et al:Blood pressure management after endovascular therapy for acute ischemic stroke:the BEST-II randomized clinical trial. JAMA 330:821-831, 2023

 

5) Hsu CY, Saver JL, Ovbiagele B et al:Association between magnitude of differential blood pressure reduction and secondary stroke prevention:a meta-analysis and meta-regression. JAMA Neurol 80:506-515, 2023

 

P.131 掲載の参考文献

6) Zhan R, Zhang J, Chen X et al:Targeting the efficacy of intensive blood pressure treatment in hypertensive patients - an exploratory analysis of SPRINT. Circ J 87:1212-1218, 2023

 

7) Ho VS, Cenzer IS, Nguyen BT et al:Time to benefit for stroke reduction after blood pressure treatment in older adults:a meta-analysis. J Am Geriatr Soc 70:1558-1568, 2022

 

8) Gaba P, O'Donoghue ML, Park JG et al:Association between achieved lowdensity lipoprotein cholesterol levels and long-term cardiovascular and safety outcomes:an analysis of FOURIER-OLE. Circulation 147:1192-1203, 2023

 

9) San X, Lv Z, Xu P et al:The prevention of stroke by statins:a meta-analysis. Medicine (Baltimore) 101:e30606, 2022

 

P.132 掲載の参考文献

10) Khan SU, Yedlapati SH, Lone AN et al:PCSK9 inhibitors and ezetimibe with or without statin therapy for cardiovascular risk reduction:a systematic review and network meta-analysis. BMJ 377:e069116, 2022

 

11) Lee B, Hong SJ, Rha SW et al:Moderate-intensity statin plus ezetimibe vs high-intensity statin according to baseline LDL-C in the treatment of atherosclerotic cardiovascular disease:a post-hoc analysis of the RACING randomized trial. Atherosclerosis 386:117373, 2023

 

12) Lee YJ, Cho JY, You SC et al:Moderate-intensity statin with ezetimibe vs. high-intensity statin in patients with diabetes and atherosclerotic cardiovascular disease in the RACING trial. Eur Heart J 44:972-983, 2023

 

13) Betrisey S, Haller ML, Efthimiou O et al:Lipid-lowering therapy and risk of hemorrhagic stroke:a systematic review and meta-analysis of randomized controlled trials. J Am Heart Assoc 13:e030714, 2024

 

14) Das Pradhan A, Glynn RJ, Fruchart JC et al:Triglyceride lowering with pemafibrate to reduce cardiovascular risk. N Engl J Med 387:1923-1934, 2022

 

15) Olshansky B, Bhatt DL, Miller M et al:Cardiovascular benefits of icosapent ethyl in patients with and without atrial fibrillation in REDUCE-IT. J Am Heart Assoc 12:e026756, 2023

 

16) Xu Q, Du L, Gu H et al:The effect of omega-3 polyunsaturated fatty acids on stroke treatment and prevention:a systematic review and meta-analysis. Nutr Hosp 39:924-935, 2022

 

17) Lv X, Liu X, Peng Y et al:Medium-intensity statin with ezetimibe versus high-intensity statin in acute ischemic cerebrovascular disease (MESIA):a randomized clinical trial. J Stroke Cerebrovasc Dis 33:107647, 2024

 

P.133 掲載の参考文献

18) Yin Y, Zhang L, Marshall I et al:Statin therapy for preventing recurrent stroke in patients with ischemic stroke:a systematic review and meta-analysis of randomized controlled trials and observational cohort studies. Neuroepidemiology 56:240-249, 2022

 

19) Lee M, Cheng CY, Wu YL et al:Association between intensity of low-density lipoprotein cholesterol reduction with statin-based therapies and secondary stroke prevention:a meta-analysis of randomized clinical trials. JAMA Neurol 79:349-358, 2022

 

20) Zheng H, Li H, Wang Y et al:Rosuvastatin slows progression of carotid intima-media thickness:the METEOR-China randomized controlled study. Stroke 53:3004-3013, 2022

 

21) Zhang T, Liang Z, Lin T et al:Cost-effectiveness of folic acid therapy for primary prevention of stroke in patients with hypertension. BMC Med 20:407, 2022

 

22) Bao H, Huang X, Li P et al:Combined use of amlodipine and folic acid are significantly more efficacious than amlodipine alone in lowering plasma homocysteine and blood pressure among hypertensive patients with hyperhomocysteinemia and intolerance to ACEI:a multicenter, randomized, double-blind, parallel-controlled clinical trial. J Clin Hypertens (Greenwich) 25:689-699, 2023

 

23) Lee SE, Nam H, Choi HS et al:Comparative effects of sodium-glucose cotransporter 2 inhibitor and thiazolidinedione treatment on risk of stroke among patients with type 2 diabetes mellitus. Diabetes Metab J 46:567-577, 2022

 

24) Rahman H, Khan SU, Lone AN et al:Sodium-glucose cotransporter-2 inhibitors and primary prevention of atherosclerotic cardiovascular disease:a meta-analysis of randomized trials and systematic review. J Am Heart Assoc 12:e030578, 2023

 

P.134 掲載の参考文献

25) Wang ZM, Chen B, Zhou B et al:Green tea consumption and the risk of stroke:a systematic review and meta-analysis of cohort studies. Nutrition 107:111936, 2023

 

26) Wang ZM, Bu XX, Zhou B et al:Dietary calcium intake and the risk of stroke:meta-analysis of cohort studies. Nutr Metab Cardiovasc Dis 33:934-946, 2023

 

27) Anadani M, Turan TN, Yaghi S et al:Change in smoking behavior and outcome after ischemic stroke:post-hoc analysis of the SPS3 trial. Stroke 54:921-927, 2023

 

28) Ihl T, Ahmadi M, Laumeier I et al:Patient-centered outcomes in a randomized trial investigating a multimodal prevention program after transient ischemic attack or minor stroke:the INSPiRE-TMS trial. Stroke 53:2730-2738, 2022

 

III章 脳外傷

P.137 掲載の参考文献

1) Encarnacion Ramirez MJ, Barrientos Castillo RE, Vorobiev A et al:Basal cisternostomy for traumatic brain injury:a case report of unexpected good recovery. Chin J Traumatol 25:302-305, 2022

 

2) Giammattei L, Starnoni D, Messerer M et al:Basal cisternostomy for severe TBI:surgical technique and cadaveric dissection. Front Surg 9:915818, 2022

 

3) Chandra VVR, Mowliswara Prasad BC, Banavath HN et al:Cisternostomy versus decompressive craniectomy for the management of traumatic brain injury:a randomized controlled trial. World Neurosurg 162:e58-e64, 2022

 

4) Kumari S, Jaiswal M, Ojha BK:Is basal cisternostomy in traumatic brain injury a need of hour or white elephant - a randomized trial to answer. Surg Neurol Int 14:412, 2023

 

5) Liu J, Zhang S, Chen Y et al:Cisternostomy is not beneficial to reduce the occurrence of post-traumatic hydrocephalus in traumatic brain injury. Acta Neurochir (Wien) 166:200, 2024

 

P.138 掲載の参考文献

6) Hutchinson PJ, Adams H, Mohan M et al:Decompressive craniectomy versus craniotomy for acute subdural hematoma. N Engl J Med 388:2219-2229, 2023

 

7) van Essen TA, van Erp IAM, Lingsma HF et al:Comparative effectiveness of decompressive craniectomy versus craniotomy for traumatic acute subdural hematoma (CENTER-TBI):an observational cohort study. EClinicalMedicine 63:102161, 2023

 

8) Habibi MA, Kobets AJ, Boskabadi AR et al:A comprehensive systematic review and meta-analysis study in comparing decompressive craniectomy versus craniotomy in patients with acute subdural hematoma. Neurosurg Rev 47:77, 2024

 

9) Shafique MA, Mustafa MS, Luke-Wold B et al:Surgical strategies in acute subdural hematoma:a meta-analysis of decompressive craniectomy vs. craniotomy. Acta Neurochir (Wien) 166:121, 2024

 

10) Nadeem A, Siddiqui T, Rais T et al:Comparing surgical outcomes:craniotomy versus decompressive craniectomy in acute subdural hematoma - a systematic review and meta-analysis. World Neurosurg X 23:100368, 2024

 

11) Vreeburg RJG, Singh RD, van Erp IAM et al:Early versus delayed cranioplasty after decompressive craniectomy in traumatic brain injury:a multicenter observational study within CENTER-TBI and Net-QuRe. J Neurosurg, 2024. doi:10.3171/2024.1.JNS232172

 

P.139 掲載の参考文献

12) Shibahashi K, Ohbe H, Matsui H et al:Real-world benefit of intracranial pressure monitoring in the management of severe traumatic brain injury:a propensity score matching analysis using a nationwide inpatient database. J Neurosurg 139:1514-1522, 2023

 

13) Waack AL, Lucarelli V, Leverich M et al:Patterns and outcomes of intracranial pressure monitoring in traumatic brain injury:an analysis of the National Inpatient Sample. Clin Neurol Neurosurg 238:108168, 2024

 

14) Payen JF, Launey Y, Chabanne R et al:Intracranial pressure monitoring with and without brain tissue oxygen pressure monitoring for severe traumatic brain injury in France (OXY-TC):an open-label, randomized controlled superiority trial. Lancet Neurol 22:1005-1014, 2023

 

15) Santana LS, Diniz JBC, Solla DJF et al:Brain tissue oxygen combined with intracranial pressure monitoring versus isolated intracranial pressure monitoring in patients with traumatic brain injury:an updated systematic review and meta-analysis. Neurol Sci, 2024. doi:10.1007/s10072-024-07392-0

 

P.140 掲載の参考文献

16) Svedung Wettervik T, Beqiri E, Hanell A et al:Visualization of cerebral pressure autoregulatory insults in traumatic brain injury. Crit Care Med, 2024. doi:10.1097/CCM.0000000000006287

 

17) Laic RAG, Verhamme P, Vander Sloten J et al:Long-term outcomes after traumatic brain injury in elderly patients on antithrombotic therapy. Acta Neurochir (Wien) 165:1297-1307, 2023

 

18) Pan L, Hu J:Effect of prior anticoagulation therapy on outcomes of traumatic brain injury:a systematic review and metaanalysis. Exp Ther Med 27:160, 2024

 

19) O'Donohoe RB, Lee HQ, Tan T et al:The impact of preinjury antiplatelet and anticoagulant use on elderly patients with moderate or severe traumatic brain injury following traumatic acute subdural hematoma. World Neurosurg 166:e521-e527, 2022

 

P.141 掲載の参考文献

20) Yorkgitis BK, Tatum DM, Taghavi S et al:Eastern association for the surgery of trauma multicenter trial:comparison of pre-injury antithrombotic use and reversal strategies among severe traumatic brain injury patients. J Trauma Acute Care Surg 92:88-92, 2022

 

21) Vattipally VN, Ran KR, Giwa GA et al:Impact of antithrombotic medications and reversal strategies on the surgical management and outcomes of traumatic acute subdural hematoma. World Neurosurg 182:e431-e441, 2024

 

22) Sheth KN, Solomon N, Alhanti B et al:Time to anticoagulation reversal and outcomes after intracerebral hemorrhage. JAMA Neurology 81:363-372, 2024

 

23) Rychen J, Weiger VF, Halbeisen FS et al:Perioperative continuation or ultra-early resumption of antithrombotics in elective neurosurgical cranial procedures. Neurosurg Focus 55:E6, 2023

 

P.142 掲載の参考文献

1) Patricios JS, Schneider KJ, Dvorak J et al:Consensus statement on concussion in sport:the 6th International Conference on Concussion in Sport-Amsterdam, October 2022. Br J Sports Med 57:695-711, 2023

 

2) 荻野雅宏, 中山晴雄, 荒木尚 他:スポーツによる脳振盪に関する共同声明-第6回国際スポーツ脳振盪会議(アムステルダム, 2022)-日本語版. 神経外傷 (in submission)

 

P.143 掲載の参考文献

3) Echemendia RJ, Brett BL, Broglio S et al:Sport concussion assessment tool(TM)-6 (SCAT6). Br J Sports Med 57:622-631, 2023

 

4) Davis GA, Echemendia RJ, Ahmed OH et al:Child SCAT6. Br J Sports Med 57:636-647, 2023

 

5) Echemendia RJ, Ahmed OH, Bailey CM et al:The Concussion Recognition Tool 6 (CRT6). Br J Sports Med 57:692-694, 2023

 

6) Patricios J, Schneider GM, van Ierssel J et al:Sport Concussion Office Assessment Tool 6 (SCOAT6). Br J Sports Med 2023:651-667, 2023

 

7) Davis GA, Patricios JS, Purcell LK et al:Child SCOAT6. Br J Sports Med 57:672-688, 2023

 

8) 日本脳神経外傷学会スポーツ脳神経外傷検討委員会:脳振盪を疑ったときのツール. http://sports.hc.keio.ac.jp/ja/athlete-support/files/2020/5/8/26f5c581548b9dd3b074a24343ad8704.pdf

 

P.144 掲載の参考文献

9) Leddy JJ, Burma JS, Toomey CM et al:Rest and exercise early after sport-related concussion:a systematic review and meta-analysis. Br J Sports Med 57:762-770, 2023

 

10) Macnow T, Curran T, Tolliday C et al:Effect of screen time on recovery from concussion:a randomized clinical trial. JAMA Pediatr 175:1124-1131, 2021

 

11) Cairncross M, Yeates KO, Tang K et al:Early postinjury screen time and concussion recovery. Pediatrics 150:e2022056835, 2022

 

12) Leddy JJ, Master CL, Mannix R et al:Early targeted heart rate aerobic exercise versus placebo stretching for sport-related concussion in adolescents:a randomized controlled trial. Lancet Child Adolesc Health 5:792-799, 2021

 

13) Trbovich AM, Howie EK, Elbin RJ et al:The relationship between accelerometer measured sleep and next day ecological momentary assessment symptom report during sport-related concussion recovery. Sleep Health 7:519-525, 2021

 

P.145 掲載の参考文献

14) Schneider KJ, Critchley ML, Anderson V et al:Targeted interventions and their effect on recovery in children, adolescents and adults who have sustained a sportrelated concussion:a systematic review. Br J Sports Med 57:771-779, 2023

 

15) Eliason P, Galarneau JM, Kolstad AT et al:Prevention strategies and modifiable risk factors for sport-related concussions and head impacts:a systematic review and meta-analysis. Br J Sports Med 57:749-761, 2023

 

16) Katz DI, Bernick C, Dodick DW et al:National Institute of neurological disorders and stroke consensus diagnostic criteria for traumatic encephalopathy syndrome. Neurology 96:848-863, 2021

 

P.146 掲載の参考文献

17) Daneshvar DH, Mez J, Alosco ML et al:Incidence of and mortality from amyotrophic lateral sclerosis in National Football League athletes. JAMA Netw Open 4:e2138801, 2021

 

18) Pupillo E, Bianchi E, Vanacore N et al:Increased risk and early onset of ALS in professional players from Italian soccer teams. Amyotroph Lateral Scler Frontotemporal Degener 21:403-409, 2020

 

19) Tabor JB, Brett BL, Nelson L et al:Role of biomarkers and emerging technologies in defining and assessing neurobiological recovery after sport-related concussion:a systematic review. Br J Sports Med 57:789-797, 2023

 

20) Makdissi M, Critchley ML, Cantu RC et al:When should an athlete retire or discontinue participating in contact or collision sports following sport-related concussion? A systematic review. Br J Sports Med 57:822-830, 2023

 

21) Willick SE, Lexell J:Paralympic sports medicine and sports science - introduction. PM R 6 (8 Suppl):S1-S3, 2014

 

22) Derman W, Runciman P, Jordaan E:High incidence of injuries at the Pyeongchang 2018 Paralympic Winter Games:a prospective cohort study of 6804 athlete days. Br J Sports Med 54:38-43, 2020

 

P.148 掲載の参考文献

1) Christian CW, Block R;Committee on Child Abuse and Neglect;American Academy of Pediatrics:Abusive head trauma in infants and children. Pediatrics 123:1409-1411, 2009

 

2) こども家庭庁:こども虐待による死亡事例等の検証結果等について(第19次報告)(令和5年9月). 個別調査票による死亡事例の調査報告. https://www.cfa.go.jp/assets/contents/node/basic_page/field_ref_resources/c36a12d5-fb29-481d-861c-a7fea559909d/f31e8d7f/20230905_councils_shingikai_gyakutai_boushihogojirei_19-houkoku_07.pdf

 

3) こども家庭庁:令和4年度児童相談所における児童虐待相談対応件数とその推移. https://www.cfa.go.jp/assets/contents/node/basic_page/field_ref_resources/a176de99-390e-4065-a7fb-fe569ab2450c/12d7a89f/20230401_policies_jidougyakutai_19.pdf

 

4) 宮本信也:子ども虐待のいま. チャイルドヘルス 26:166-169, 2023

 

P.149 掲載の参考文献

5) 天笠俊介, 辻聡, 守谷俊:日本における虐待頭部外傷診療の問題点. 日救急医会誌 31:112-119, 2020

 

6) 山田不二子, 丸山朋子, 相田典子 他:AHT診断アルゴリズム(診断の手引き). 2022年9月1日第2版.

 

7) 田村正徳, 中村肇, 奥山眞紀子 他;厚生労働省・神経疾患研究委託費研究班:「虐待が疑われる乳幼児頭部外傷(Abusive head trauma in infants and young children, AHT)」の診断・治療・予防の手引き. 2009

 

8) Duhaime AC, Christian CW:Abusive head trauma:evidence, obfuscation, and informed management. J Neurosurg Pediatr 24:481-488, 2019

 

9) Narisawa A, Nonaka M, Akutsu N et al: Unexplained mechanism of subdural hematoma with convulsion suggests nonaccidental head trauma:a multicenter, retrospective study by the Japanese Head injury of Infants and Toddlers study (JHITs) group. PLoS One 17:e0277103, 2022

 

10) 宮坂実木子:虐待による乳幼児頭部外傷. 日小児放射線会誌 36:91-100, 2020

 

P.150 掲載の参考文献

11) Wright JN:CNS injuries in abusive head trauma. AJR Am J Roentgenol 208:991-1001, 2017

 

12) Choudhary AK, Ishak R, Zacharia TT et al:Imaging of spinal injury in abusive head trauma:a retrospective study. Pediatric Radiol 44:1130-1140, 2014

 

13) 吉野智美, 古家信介, 石川順一 他:Abusive Head Traumaの退院時神経学的転帰 不良例の臨床的特徴. 日救急医会誌 33:103-109, 2022

 

14) Takanashi J:Two newly proposed encephalitis/encephalopathy syndromes. Brain Dev 31:521-528, 2009

PubMed

15) Takanashi J, Mizuguchi M, Terai M et al:Disrupted glutamate-glutamine cycle in acute encephalopathy with bi-phasic seizures and late reduced diffusion. Neuroradiology 57:1163-1168. 2015

 

16) Takanashi J, Tada H, Terada H et al:Excitotoxicity in acute encephalopathy with biphasic seizures and late reduced diffusion. AJNR Am J Neuroraiol. 30:132-135, 2009

 

17) Takase N, Igarashi N, Taneichi H et al:Infantile traumatic brain injury with a biphasic clinical course and late reduced diffusion. J Neurol Sci 390:63-66, 2018

 

18) Wang HC, Tsai JC, Lee JE et al:Direct visualization of microcirculation impairment after acute subdural hemorrhage in a novel animal model. J Neurosurg 129:997-1007, 2018

 

P.151 掲載の参考文献

19) Suh DW, Song HH, Mozafari H et al:Determining the tractional forces on vitreoretinal interface using a computer simulation model in abusive head trauma. Am J Ophthalmol 223:396-404, 2021

 

20) Maguire SA, Watts PO, Shaw AD et al:Retinal haemorrhages and related findings in abusive and non-abusive head trauma:a systematic review. Eye (Lond) 27:28-36, 2013

 

21) Christian CW, Levin AV;Council on Child Abuse and Neglect et al:The eye examination in the evaluation of child abuse. Pediatrics 142:e20181411, 2018

 

22) Hymel KP, Carroll CL, Frazier TN et al:Validation of the PediBIRN-7 clinical prediction rule for pediatric abusive head trauma. Child Abuse Negl 152:106799, 2024

 

P.152 掲載の参考文献

23) Pfeiffer H, Cowley LE, Kemp AM et al:Validation of the PredAHT-2 prediction tool for abusive head trauma. Emerg Med J 37:119-126, 2020

 

24) Okuzono S, Fujiwara T, Kato T er al:Spanking and subsequent behavioral problems in toddlers:a propensity score-matched, prospective study in Japan. Child Abuse Negl 69:62-71, 2017

 

P.153 掲載の参考文献

25) Fujiwara T, Isumi A, Sampei M et al:Effectiveness of using an educational video simulating the anatomical mechanism of shaking and smothering in a home-visit program to prevent self-reported infant abuse:a population-based quasi-experimental study in Japan. Child Abuse Negl 101:104359, 2020

 

26) Scott LJ, Wilson R, Davies P et al:Educational interventions to prevent paediatric abusive head trauma in babies younger than one year old:a systematic review and meta-analyses. Child Abuse Negl 134:105935, 2022

 

27) 小橋孝介:医療機関向け虐待対応啓発プログラムBEAMS(ビームス)～わが国の子ども虐待対応の均霑化に向けて～. 外来小児科 23:60-64, 2020

 

P.154 掲載の参考文献

1) American Congress of Rehabilitation Medicine, Brain Injury Interdisciplinary Special Interest Group, Disorders of Consciousness Task Force:Definition of mild traumatic brain injury. J Head Trauma Rehabil 8:86-87, 1993

 

P.155 掲載の参考文献

2) Silverberg ND, Iverson GL;ACRM Mild TBI Definition Expert Consensus Group and the ACRM Brain Injury Special Interest Group Mild TBI Task Force:Expert panel survey to update the American Congress of Rehabilitation Medicine definition of mild traumatic brain injury. Arch Phys Med Rehabil 102:76-86, 2021

 

3) Silverberg ND, Iverson GL;ACRM Brain Injury Special Interest Group Mild TBI Task Force members:The American Congress of Rehabilitation Medicine diagnostic criteria for mild traumatic brain injury. Arch Phys Med Rehabil 104:1343-1355, 2023

 

4) Bryant AM, Rose NB, Temkin NR et al:Profiles of cognitive functioning at 6 months after traumatic brain injury among patients in level I trauma centers:a TRACK-TBI study. JAMA Netw Open 6:e2349118, 2023

 

P.156 掲載の参考文献

5) Shahim P, Zetterberg H:Neurochemical markers of traumatic brain injury:relevance to acute diagnostics, disease monitoring, and neuropsychiatric outcome prediction. Biol Psychiatry 91:405-412, 2022

 

6) Bernick C, Shan G, Ritter A et al:Blood biomarkers and neurodegeneration in individuals exposed to repetitive head impacts. Alzheimers Res Ther 15:173, 2023

 

P.157 掲載の参考文献

7) Schneider ALC, Huie JR, Boscardin WJ et al:Cognitive outcome 1 year after mild traumatic brain injury:results from the TRACK-TBI study. Neurology 98:e1248-e1261, 2022

 

8) Lennon MJ, Brooker H, Creese B et al:Lifetime traumatic brain injury and cognitive domain deficits in late life:the PROTECT-TBI cohort study. J Neurotrauma 40:1423-1435, 2023

 

P.158 掲載の参考文献

9) Chanti-Ketterl M, Pieper CF, Yaffe K et al:Associations between traumatic brain injury and cognitive decline among older male veterans:a twin study. Neurology 101:e1761-e1770, 2023

 

10) Haarbauer-Krupa J, Pugh MJ, Prager EM et al:Epidemiology of chronic effects of traumatic brain injury. J Neurotrauma 38:3235-3247, 2021

 

P.159 掲載の参考文献

11) Wright TJ, Elliott TR, Randolph KM et al:Prevalence of fatigue and cognitive impairment after traumatic brain injury. PLoS One 19:e0300910, 2024

 

12) Robertson-Benta CR, Pabbathi Reddy S, Stephenson DD et al:Cognition and post-concussive symptom status after pediatric mild traumatic brain injury. Child Neuropsychol 30:203-220, 2024

 

P.160 掲載の参考文献

13) Clark E, Faruque S, Mutebi C et al:Investigating the relationship between mild traumatic brain injury and Alzheimer's disease and related dementias:a systematic review. J Neurol 269:4635-4645, 2022

 

IV章 定位・機能

P.162 掲載の参考文献

1) Misra S, Kasner SE, Dawson J et al:Outcomes in patients with poststroke seizures:a systematic review and meta-analysis. JAMA Neurol 80:1155-1165, 2023

 

2) Yoshimura H, Tanaka T, Fukuma K et al;PROPOSE Study Investigators:Impact of seizure recurrence on 1-year functional outcome and mortality in patients with poststroke epilepsy. Neurology 99:e376-e384, 2022

 

3) Hou H, Sun G, Duan Z et al:Clinical characteristics of cognitive impairment and its related risk factors in post-stroke epilepsy. Epileptic Disord 24:677-686, 2022

 

4) Stefanidou M, Himali JJ, Devinsky O et al:Vascular risk factors as predictors of epilepsy in older age:the Framingham Heart Study. Epilepsia 63:237-243, 2022

 

P.163 掲載の参考文献

5) Liu F, Chen D, Fu Y et al:Incidence and association of seizures in stroke patients following endovascular treatment:a systematic review and meta-analysis. Eur J Neurol 30:134-143, 2023

 

6) Tanaka T, Fukuma K, Abe S et al:Association of cortical superficial siderosis with post-stroke epilepsy. Ann Neurol 93:357-370, 2023

 

7) Sinka L, Abraira L, Imbach LL et al:Association of mortality and risk of epilepsy with type of acute symptomatic seizure after ischemic stroke and an updated prognostic model. JAMA Neurol 80:605-613, 2023

 

8) Huang L, Fu C, Li J et al:Late-onset epilepsy and the risk of dementia:a systematic review and meta-analysis. Aging Clin Exp Res 34:1771-1779, 2022

 

9) Helmstaedter C, Lutz T, Wolf V et al:Prevalence of dementia in a level 4 university epilepsy center:how big is the problem? Front Neurol 14:1217594, 2023

 

10) Tai XY, Torzillo E, Lyall DM et al:Association of dementia risk with focal epilepsy and modifiable cardiovascular risk factors. JAMA Neurol 80:445-454, 2023

 

11) Zhang X, Ahmed R, Thayer Z et al:Late-onset epilepsy with cognitive symptoms:Comparison of cognitive and imaging profiles with probable Alzheimer's disease. Epilepsy Behav 146:109371, 2023

 

12) Hernandez G, Sala-Padro J, Adell V et al:Cognitive decline in adult-onset temporal lobe epilepsy:insights from aetiology. Clin Neurol Neurosurg 237:108159, 2024

 

13) Ha J, Son NH, Park YH et al:Association of cognitive enhancers and incident seizure risk in dementia:a population-based study. BMC Geriatr 22:480, 2022

 

14) Hodges JR, Warlow CP:Syndromes of transient amnesia:towards a classification. a study of 153 cases. J Neurol Neurosurg Psychiatry 53:834-843, 1990

 

15) Zeman AZ, Boniface SJ, Hodges JR:Transient epileptic amnesia:a description of the clinical and neuropsychological features in 10 cases and a review of the literature. J Neurol Neurosurg Psychiatry 64:435-443, 1998

 

P.164 掲載の参考文献

16) Sancetta BM, Ricci L, Assenza G et al:EPIAMNE:a new scoring system for differentiating transient EPIleptic AMNEsia from transient global amnesia. Brain Sci 12:1632, 2022

 

17) Cretin B, Philippi N, Bousiges O et al:Transient epileptic amnesia:a retrospective cohort study of 127 cases, including CSF amyloid and tau features. J Neurol 270:2256-2270, 2023

 

18) Lam AD, Deck G, Goldman A et al:Silent hippocampal seizures and spikes identified by foramen ovale electrodes in Alzheimer's disease. Nat Med 23:678-680, 2017

 

19) Vossel KA, Ranasinghe KG, Beagle AJ et al:Incidence and impact of subclinical epileptiform activity in Alzheimer's disease. Ann Neurol 80:858-870, 2016

PubMed

20) Devulder A, Macea J, Kalkanis A et al:Subclinical epileptiform activity and sleep disturbances in Alzheimer's disease. Brain Behav 13:e3306, 2023

 

21) Dun C, Zhang Y, Yin J et al:Bi-directional associations of epilepsy with dementia and Alzheimer's disease:a systematic review and meta-analysis of longitudinal studies. Age Ageing 51:afac010, 2022

 

22) Leo A, Tallarico M, Sciaccaluga M et al:Epilepsy and Alzheimer's disease:current concepts and treatment perspective on two closely related pathologies. Curr Neuropharmacol 20:2029-2033, 2022

 

23) Elo J, Tolppanen AM, Koponen M et al:Recent hospitalization and initiation of antiepileptics among persons with Alzheimer's disease. J Am Med Dir Assoc 24:213-219. e6, 2023

 

24) Gouilly D, Vrillon A, Bertrand E et al:Translocator protein (TSPO) genotype does not change cerebrospinal fluid levels of glial activation, axonal and synaptic damage markers in early Alzheimer's disease. Neuroimage Clin 43:103626, 2024

 

25) Negi D, Granak S, Shorter S et al:Molecular biomarkers of neuronal injury in epilepsy shared with neurodegenerative diseases. Neurotherapeutics 20:767-778, 2023

 

P.165 掲載の参考文献

26) Tong J, Ji T, Liu T et al:Efficacy and safety of six new antiseizure medications for adjunctive treatment of focal epilepsy and epileptic syndrome:a systematic review and network meta-analysis. Epilepsy Behav 152:109653, 2024

 

27) Talwar A, Estes E, Aparasu R et al:Clinical efficacy and safety of cannabidiol for pediatric refractory epilepsy indications:a systematic review and meta-analysis. Exp Neurol 359:114238, 2023

 

28) Tzadok M, Gur-Pollack R, Florh H et al:Real-life experience with purified cannabidiol treatment for refractory epilepsy:a multicenter retrospective study. Pediatr Neurol 150:91-96, 2024

 

29) Solmi M, De Toffol M, Kim JY et al:Balancing risks and benefits of cannabis use:umbrella review of meta-analyses of randomised controlled trials and observational studies. BMJ 382:e072348, 2023

 

30) Perriguey M, Succar ME, Clement A et al:High-purified cannabidiol efficacy and safety in a cohort of adult patients with various types of drug-resistant epilepsies. Rev Neurol (Paris) 180:147-153, 2024

 

31) Szaflarski JP, Devinsky O, Lopez M et al:Long-term efficacy and safety of cannabidiol in patients with treatment-resistant epilepsies:four-year results from the expanded access program. Epilepsia 64:619-629, 2023

 

32) Peltola J, Colon AJ, Pimentel J et al;MORE Study Group:Deep brain stimulation of the anterior nucleus of the thalamus in drug-resistant epilepsy in the MORE multicenter patient registry. Neurology 100:e1852-e1865, 2023

 

P.166 掲載の参考文献

33) Fisher R, Salanova V, Witt T et al;SANTE Study Group:Electrical stimulation of the anterior nucleus of thalamus for treatment of refractory epilepsy. Epilepsia 51:899-908, 2010

 

P.167 掲載の参考文献

1) Touma L, Dansereau B, Chan AY et al:Neurostimulation in people with drugresistant epilepsy:systematic review and meta-analysis from the ILAE Surgical Therapies Commission. Epilepsia 63:1314-1329, 2022

 

P.168 掲載の参考文献

2) Kostov KH, Kostov H, Larsson PG et al:Norwegian population-based study of longterm effects, safety, and predictors of response of vagus nerve stimulation treatment in drug-resistant epilepsy:the NORPulse study. Epilepsia 63:414-425, 2022

 

3) Bagic AI, Verner R, Afra P et al;ASCEND Study Group:ASCEND:a randomized controlled trial of titration strategies for vagus nerve stimulation in drug-resistant epilepsy. Epilepsy Behav 145:109333, 2023

 

4) Peltola J, Colon AJ, Pimentel J et al;MORE Study Group:Deep brain stimulation of the anterior nucleus of the thalamus in drug-resistant epilepsy in the MORE multicenter patient registry. Neurology 100:e1852-e1865, 2023

 

5) Dalic LJ, Warren AEL, Bulluss KJ et al:DBS of thalamic centromedian nucleus for lennox-gastaut syndrome (ESTEL Trial). Ann Neurol 91:253-267, 2022

 

P.169 掲載の参考文献

6) Fields MC, Eka O, Schreckinger C et al:A multicenter retrospective study of patients treated in the thalamus with responsive neurostimulation. Front Neurol 14:1202631, 2023

 

7) Singh RK, Eschbach K, Samanta D et al:Responsive neurostimulation in drug-resistant pediatric epilepsy:findings from the epilepsy surgery subgroup of the Pediatric Epilepsy Research Consortium. Pediatr Neurol 143:106-112, 2023

 

P.170 掲載の参考文献

8) Zou X, Shi Y, Wu X et al:Efficacy of short pulse and conventional deep brain stimulation in Parkinson's disease:a systematic review and meta-analysis. Neurol Science 44:815-825, 2023

 

9) Schnitzler A, Mir P, Brodsky MA et al;PROGRESS Study Investigators:Directional deep brain stimulation for Parkinson's disease:results of an international crossover study with randomized, double-blind primary endpoint. Neuromodulation 25:817-828, 2022

 

10) Kapural L, Patterson DG, Li S et al:Multiphase spinal cord stimulation in participants with chronic back or leg pain:results of the BENEFIT-02 randomized clinical trial. Neuromodulation 26:1400-1411, 2023

 

11) Wang D, Lu Y, Han Y et al:The influence of etiology and stimulation target on the outcome of deep brain stimulation for chronic neuropathic pain:a systematic review and meta-analysis. Neuromodulation 27:83-94, 2024

 

12) Liu C, Li L, Li B et al:Efficacy and safety of theta burst vs repetitive transcranial magnetic stimulation for the treatment of depression:a meta-analysis of randomized controlled trials. Neuromodulation, 2023. doi:10.1016/j.neurom.2023.08.009

 

P.171 掲載の参考文献

13) Remore LG, Tolossa M, Wei W et al:Deep brain stimulation of the medial forebrain bundle for treatment-resistant depression:a systematic review focused on the long-term antidepressive effect. Neuromodulation, 2023. doi:10.1016/j.neurom.2023.03.011

 

14) Rubin DB, Ajiboye AB, Barefoot L et al:Interim safety profile from the feasibility study of the BrainGate Neural Interface system. Neurology 100:e1177-e1192, 2023

 

15) Lycke R, Kim R, Zolotavin P et al:Low-threshold, high-resolution, chronically stable intracortical microstimulation by ultraflexible electrodes. Cell Rep 42:112554, 2023

 

16) Angrick M, Luo S, Rabbani Q et al:Online speech synthesis using a chronically implanted brain-computer interface in an individual with ALS. Sci Rep 14:9617, 2024

 

17) Zhang Q, Hu S, Talay R et al:A prototype closed-loop brain-machine interface for the study and treatment of pain. Nat Biomed Eng 7:533-545, 2023

 

P.172 掲載の参考文献

18) Catalan JM, Trigili E, Nann M et al:Hybrid brain/neural interface and autonomous vision-guided whole-arm exoskeleton control to perform activities of daily living (ADLs). J Neuroeng Rehabil 20:61, 2023

 

19) Jia T, Li C, Mo L et al:Tailoring brain-machine interface rehabilitation training based on neural reorganization:towards personalized treatment for stroke patients. Cereb Cortex 33:3043-3052, 2023

 

20) Tang J, LeBel A, Jain S et al:Semantic reconstruction of continuous language from non-invasive brain recordings. Nat Neurosci 26:858-866, 2023

 

21) Kim S, Moon HS, Vo TT et al:Whole-brain mapping of effective connectivity by fMRI with cortex-wide patterned optogenetics. Neuron 111:1732-1747. e6, 2023

 

22) Griggs WS, Norman SL, Deffieux T et al:Decoding motor plans using a closed-loop ultrasonic brain-machine interface. Nat Neurosci 27:196-207, 2024

 

P.173 掲載の参考文献

23) Guo Y, Sun L, Zhong W et al:Artificial intelligence-assisted repair of peripheral nerve injury:a new research hotspot and associated challenges. Neural Regen Res 19:663-670, 2024

 

24) Sujatha Ravindran A, Contreras-Vidal J:An empirical comparison of deep learning explainability approaches for EEG using simulated ground truth. Sci Rep 13:17709, 2023

 

P.174 掲載の参考文献

1) Schmidt SL, Chowdhury AH, Mitchell KT et al:At home adaptive dual target deep brain stimulation in Parkinson's disease with proportional control. Brain 147:911-922, 2024

 

P.175 掲載の参考文献

2) Marceglia S, Conti C, Svanidze O et al:Double-blind cross-over pilot trial protocol to evaluate the safety and preliminary efficacy of long-term adaptive deep brain stimulation in patients with Parkinson's disease. BMJ open 12:e049955, 2022

 

3) Sarica C, Zemmar A, Yousefi O:Spinal cord stimulation for Parkinson's disease:a systematic review and meta-analysis of pain and motor outcomes. Stereotact Funct Neurosurg 101:244-253, 2023

 

P.176 掲載の参考文献

4) Milekovic T, Moraud EM, Macellari N et al:A spinal cord neuroprosthesis for locomotor deficits due to Parkinson's disease. Nat Med 29:2854-2865, 2023

 

P.177 掲載の参考文献

5) Blesa J, Pineda-Pardo JA, Inoue KI et al:BBB opening with focused ultrasound in nonhuman primates and Parkinson's disease patients:targeted AAV vector delivery and PET imaging. Sci Adv 9:eadf4888, 2023

 

6) Lin S, Shu Y, Zhang C et al:Globus pallidus internus versus subthalamic nucleus deep brain stimulation for isolated dystonia:a 3-year follow-up. Eur J Neurol 30:2629-2640, 2023

 

7) Hock AN, Jensen SR, Svaerke KW et al:A randomised double-blind controlled study of Deep Brain Stimulation for dystonia in STN or GPi - a long term follow-up after up to 15 years. Parkinsonism Relat Disord 96:74-79, 2022

 

P.178 掲載の参考文献

8) Krause P, Kroneberg D, Gruber D et al:Long-term effects of pallidal deep brain stimulation in tardive dystonia:a follow-up of 5-14 years. J Neurol 269:3563-3568, 2022

 

9) Horn A, Reich MM, Ewert S et al:Optimal deep brain stimulation sites and networks for cervical vs. generalized dystonia. Proc Natl Acad Sci U S A 119:e2114985119, 2022

 

P.179 掲載の参考文献

10) Kvernmo N, Konglund AE, Reich MM et al:Deep brain stimulation for arm tremor:a randomized trial comparing two targets. Ann Neurol 91:585-601, 2022

 

P.180 掲載の参考文献

11) Blomstedt Y, Stenmark Persson R, Awad A et al:10 years follow - up of deep brain stimulation in the caudal Zona incerta/posterior subthalamic area for essential tremor. Mov Disord Clin Pract 10:783-793, 2023

 

12) Neudorfer C, Kroneberg D, Al-Fatly B et al:Personalizing deep brain stimulation using advanced imaging sequences. Ann Neurol 91:613-628, 2022

 

13) Murakami M, Horisawa S, Kim K et al:Long-term follow-up of task-specific tremor after thalamotomy:a retrospective observational study. Ann Clin Transl Neurol 11:321-327, 2024

 

P.183 掲載の参考文献

1) Cosgrove GR, Lipsman N, Lozano AM et al:Magnetic resonance imaging-guided focused ultrasound thalamotomy for essential tremor:5-year follow-up results. J Neurosurg 138:1028-1033, 2022

 

2) Fukutome K, Hirabayashi H, Osakada Y et al:Bilateral magnetic resonance imaging-guided focused ultrasound thalamotomy for essential tremor. Stereotact Funct Neurosurg 100:44-52, 2022

 

P.184 掲載の参考文献

3) Yamamoto K, Sarica C, Elias GJB et al:Ipsilateral and axial tremor response to focused ultrasound thalamotomy for essential tremor:clinical outcomes and probabilistic mapping. J Neurol Neurosurg Psychiatry, 2022. doi:10.1136/jnnp-2021-328459

 

4) Arcadi A, Aviles-Olmos I, Gonzalez-Quarante LH et al:Magnetic resonanceguided focused ultrasound (MRgFUS) -thalamotomy for essential tremor:lesion location and clinical outcomes. Mov Disord, 2024. doi:10.1002/mds.29801

 

5) Feltrin FS, Chopra R, Pouratian N et al:Focused ultrasound using a novel targeting method four-tract tractography for magnetic resonance-guided high-intensity focused ultrasound targeting. Brain Commun 4:fcac273, 2022

 

6) Germann J, Santyr B, Boutet A et al:Comparative neural correlates of DBS and MRgFUS lesioning for tremor control in essential tremor. J Neurol Neurosurg Psychiatry 95:180-183, 2024

 

7) Buchele F, Mahendran S, Uhl M et al:Impact of target depth on safety and efficacy outcomes in MR-guided focused ultrasound thalamotomy for tremor patients. J Neurosurg 140:1451-1458, 2023

 

8) Golfre Andreasi N, Braccia A, Levi V et al:The optimal targeting for focused ultrasound thalamotomy differs between dystonic and essential tremor:a 12-month prospective pilot study. Mov Disord Clin Pract 11:69-75, 2024

 

9) Swytink-Binnema CA, Coreas A, Pichardo S et al:An intraoperative accelerometry and real-time analysis tool for magnetic resonance-guided focused ultrasound thalamotomy. J Neurosurg, 2024. doi:10.3171/2024.1.JNS231830

 

10) Hino S, Maki F, Yamaguchi T et al:Effectiveness and safety of MR-guided focused ultrasound thalamotomy in patients with essential tremor and low skull density ratio:a study of 101 cases. J Neurosurg, 2024. doi:10.3171/2023.11.JNS231799

 

P.185 掲載の参考文献

11) Iijima K, Yokota H, Yamaguchi T et al:Predictors of thermal increase in magnetic resonance-guided focused ultrasound treatment for essential tremor:histogram analysis of skull density ratio values for 1024 elements. J Neurosurg 136:1381-1386, 2021

 

12) Kyle K, Peters J, Jonker B et al:Magnetic resonance-guided focused ultrasound for treatment of essential tremor:ventral intermediate nucleus ablation alone or additional posterior subthalamic area lesioning? Mov Disord Clin Pract 11:504-514, 2024

 

13) Rohringer CR, Sewell IJ, Gandhi S et al:Cognitive effects of unilateral thalamotomy for tremor:a meta-analysis. Brain Commun 4:fcac287, 2022

 

14) Saporito G, Sucapane P, Ornello R et al:Cognitive outcomes after focused ultrasound thalamotomy for tremor:results from the COGNIFUS (COGNitive in Focused UltraSound) study. Parkinsonism Relat Disord 106:105230, 2023

 

15) Bagarinao E, Maesawa S, Kato S et al:Cerebellar and thalamic connector hubs facilitate the involvement of visual and cognitive networks in essential tremor. Parkinsonism Relat Disord 121:106034, 2024

 

16) Chua MMJ, Blitz SE, Ng PR et al:Focused ultrasound thalamotomy for tremor in Parkinson's disease:outcomes in a large, prospective cohort. Mov Disord 38:1962-1967, 2023

 

17) Krishna V, Fishman PS, Eisenberg HM et al:Trial of globus pallidus focused ultrasound ablation in Parkinson's disease. N Engl J Med 388:683-693, 2023

 

P.186 掲載の参考文献

18) Martinez-Fernandez R, Natera-Villalba E, Manez Miro JU et al:Prospective longterm follow-up of focused ultrasound unilateral subthalamotomy for Parkinson disease. Neurology 100:e1395-e1405, 2023

 

19) Martinez Fernandez R, Natera Villalba E, Rodriguez-Rojas R et al:Unilateral focused ultrasound subthalamotomy in early Parkinson's disease:a pilot study. J Neurol Neurosurg Psychiatry 95:206-213, 2024

 

20) Deuschl G, Antonini A, Costa J et al:European Academy of Neurology/Movement Disorder Society-European section guideline on the treatment of Parkinson's disease:I. Invasive therapies. Mov Disord 37:1360-1374, 2022

 

P.187 掲載の参考文献

21) Blesa J, Pineda-Pardo JA, Inoue KI et al:BBB opening with focused ultrasound in nonhuman primates and Parkinson's disease patients:targeted AAV vector delivery and PET imaging. Sci Adv 9:eadf4888, 2023

 

22) Meng Y, Pople CB, Huang Y et al:Putaminal recombinant glucocerebrosidase delivery with magnetic resonance-guided focused ultrasound in Parkinson's disease:a phase I study. Mov Disord 37:2134-2139, 2022

 

23) Meng Y, Goubran M, Rabin JS et al:Blood-brain barrier opening of the default mode network in Alzheimer's disease with magnetic resonance-guided focused ultrasound. Brain 146:865-872, 2023

 

24) Rezai AR, Ranjan M, Haut MW et al:Focused ultrasound-mediated blood-brain barrier opening in Alzheimer's disease:long-term safety, imaging, and cognitive outcomes. J Neurosurg 139:275-283, 2022

 

25) Rezai AR, D'Haese PF, Finomore V et al:Ultrasound blood-brain barrier opening and aducanumab in Alzheimer's disease. N Engl J Med 390:55-62, 2024

 

26) Xhima K, Markham-Coultes K, Hahn Kofoed R et al:Ultrasound delivery of a TrkA agonist confers neuroprotection to Alzheimer-associated pathologies. Brain 145:2806-2822, 2022

 

27) Zrinzo L:Severe refractory obsessive compulsive disorder and depression:should we consider stereotactic neurosurgery? Neuropsychiatr Dis Treat 20:469-478, 2024

 

P.188 掲載の参考文献

28) Krishna V, Mindel J, Sammartino F et al:A phase 1 open-label trial evaluating focused ultrasound unilateral anterior thalamotomy for focal onset epilepsy. Epilepsia 64:831-842, 2023

 

P.189 掲載の参考文献

1) Doquenia MLM:Developments in poststroke spasticity care with early use of botulinum toxin A:a review. Journal of Medicine, University of Santo Tomas 7:1244-1251, 2023

 

P.190 掲載の参考文献

2) Suputtitada A:Emerging theory of sensitization in post-stroke muscle spasticity. Front Rehabil Sci 4:1169087, 2023

 

3) Lindsay C, Humphreys I, Phillips C et al:Estimating the cost consequence of the early use of botulinum toxin in post-stroke spasticity:secondary analysis of a randomised controlled trial. Clin Rehabil 37:373-380, 2023

 

4) Baricich A, Bertoni M, Santamato A et al:Adjunctive treatment and BoNT-A for post-stroke spasticity:are we really focusing on the patient-centered goals? Front Neurol 14:1134691, 2023

 

5) Novarella F, Carotenuto A, Cipullo P et al:Persistence with botulinum toxin treatment for spasticity symptoms in multiple sclerosis. Toxins (Basel) 14:774. 2022

 

6) Masrour M, Zare A, Presedo A et al.:Intrathecal baclofen efficacy for managing motor function and spasticity severity in patients with cerebral palsy:a systematic review and meta-analysis. BMC Neurol 24:143, 2024

 

7) Abdelmageed S, Horak VJ, Mossner J et al:Safety and efficacy of intrathecal baclofen trials for the treatment of hypertonia:a retrospective cohort study. J Neurosurg Pediatr 33:179-184, 2023

 

P.191 掲載の参考文献

8) Cho SR:Intrathecal baclofen therapy:pros and cons. Ann Rehabil Med 47:1-3, 2023

 

9) Duan H, Lian Y, Jing Y et al:Research progress in extracorporeal shock wave therapy for upper limb spasticity after stroke. Front Neurol 14:1121026, 2023

 

10) Otero-Luis I, Cavero-Redondo I, Alvarez-Bueno C et al:Effectiveness of extracorporeal shock wave therapy in treatment of spasticity of different aetiologies:a systematic review and meta-analysis. J Clin Med 13:1323, 2024

 

11) Zhang X, Ma Y:Global trends in research on extracorporeal shock wave therapy (ESWT) from 2000 to 2021. BMC Musculoskelet Disord 24:312, 2023

 

12) Chen ZJ, Li YA, Xia N et al: Effects of repetitive peripheral magnetic stimulation for the upper limb after stroke:metaanalysis of randomized controlled trials. Heliyon 22:e15767, 2023

 

P.192 掲載の参考文献

13) Allen JR, Karri SR, Yang C et al:Spinal cord stimulation for poststroke hemiparesis:a scoping review. Am J Occup Ther 7:7802180220, 2024

 

14) Yee J, Low CY, Mohamad Hashim N et al:Clinical spasticity assessment assisted by machine learning methods and rule-based decision. Diagnostics 13:739, 2023

 

15) Ho JS, Ko KS, Law SW et al:The effectiveness of robotic-assisted upper limb rehabilitation to improve upper limb function in patients with cervical spinal cord injuries:a systematic literature review. Front Neurol 14:1126755, 2023

 

16) Murakami Y, Honaga K, Kono H et al:New artificial intelligence-integrated electromyography-driven robot hand for upper extremity rehabilitation of patients with stroke:a randomized, controlled trial. Neurorehabil Neural Repair 37:298-306, 2023

 

17) Syringas P, Economopoulos T, Kouris I et al:Rehabotics:a comprehensive rehabilitation platform for post-stroke spasticity, incorporating a soft glove, a robotic exoskeleton hand and augmented reality serious games. Eng Proc 50:2, 2023

 

18) Suputtitada A, Chatromyen S, Chen CPC et al: Best practice guidelines for the management of patients with post-stroke spasticity:a modified scoping review. Toxins (Basel) 16:98, 2024

 

P.194 掲載の参考文献

1) Guan Y, Li J, Gong X et al:Safety and efficacy of hypofractionated stereotactic radiotherapy with anlotinib targeted therapy for glioblastoma at the first recurrence:a preliminary report. Brain Sci 12:471, 2022

 

P.195 掲載の参考文献

2) Grzbiela H, Nowicka E, Gawkowska M et al:Robotic stereotactic radiotherapy for intracranial meningiomas - an opportunity for radiation dose de-escalation. Cancers (Basel) 15:5436, 2023

 

3) Fatima N, La Dine AK, Barnard ZR et al:Safety and efficacy of hypofractionated stereotactic radiosurgery in facial nerve Schwannoma. Otol Neurotol 43:e841-e845, 2022

 

4) Curry SD, Kocharyan A, Lekovic GP:Multi-disciplinary approach to skull base paragangliomas. Brain Sci 13:1533, 2023

 

5) Berber T, Numanoglu C, Uysal E et al:Results of salvage treatment with CyberKnife(R) fractioned radiosurgery in recurrent large chordoma. Eur Spine J 32:244-253, 2023

 

P.196 掲載の参考文献

6) Palmer JD, Klamer BG, Ballman KV et al:Association of long-term outcomes with stereotactic radiosurgery vs whole-brain radiotherapy for resected brain metastasis:a secondary analysis of the N107C/CEC.3 (Alliance for Clinical Trials in Oncology/Canadian Cancer Trials Group) randomized clinical trial. JAMA Oncol 8:1809-1815, 2022

 

7) Grishchuk D, Dimitriadis A, Sahgal A et al:ISRS technical guidelines for stereotactic radiosurgery:treatment of small brain metastases (<- 1 cm in diameter). Pract Radiat Oncol 13:183-194, 2023

 

8) Lee J, Kim HJ, Kim WC:CyberKnifebased stereotactic radiosurgery of fractionated stereotactic radiotherapy in older patients with brain metastases from non-small cell lung cancer. Radiat Oncol J 41:258-266, 2023

 

P.197 掲載の参考文献

9) Li C, Li K, Zhong S et al:Which is the best treatment for melanoma brain metastases? A Bayesian network meta-analysis and systematic review. Crit Rev Oncol Hematol 194:104227, 2024

 

10) Franklin C, Mohr P, Bluhm L et al:Impact of radiotherapy and sequencing of systematic therapy on survival outcomes in melanoma patients with previously untreated brain metastasis:a multicenter DeCOG study on 450 patients from the prospective skin cancer registry ADOREG. J Immunother Cancer 10:e004509, 2022

 

P.198 掲載の参考文献

11) Wang HH, Tian SS, Yang JM et al:Risk-adapted stereotactic body radiotherapy for patients with cervical spinal metastases. Cancer Sci 113:4277-4288, 2022

 

12) Loebel F, Pontoriero A, Kluge A et al:Image-guided robotic radiosurgery for the treatment of arteriovenous malformations. PLos One 17:e0266744, 2022

 

13) Niwa R, Ichi S, Nomura R et al:Hypofractionated stereotactic radiosurgery with CyberKnife for large arteriovenous malformation and arteriovenous malformation located in eloquent area. Acta Neurol Med Chir (Tokyo) 62:445-450, 2022

 

P.199 掲載の参考文献

14) Luna AL, Gonzalez JA, Guardo LL et al:CyberKnife radiosurgery for refractory bilateral trigeminal neuralgia. Case report. Colom Med (Cali) 53:e5005283, 2022

 

15) Goc B, Roch-Zniszczol A, Larysz D et al:The effectiveness and toxicity of frameless CyberKnife based radiosurgery for Parkinson's disease:phaseII study. Biomedicines 11:288-297, 2023

 

16) Lovo EE, Moreira A, Cruz C et al:Radio-modulation in mixed, complex, cancer pain by triple target irradiation in the brain:a preliminary experience. Cureus 14:e25430, 2022

 

P.200 掲載の参考文献

17) Romanelli P, Beltramo G:Image-guided stereotactic radiosurgery for the treatment of spasticity and pain:a preliminary experience. Cureus 14:e24021, 2022

 

V章 小児

P.202 掲載の参考文献

1) 阪本博昭:脊髄髄膜瘤. "胎児水頭症診断と治療ガイドライン改訂第2版" 山崎麻美 編. pp104-119, 金芳堂, 2010

 

2) 近藤厚生, 多田克彦, 和田誠司 他:葉酸による神経管閉鎖障害の予防:発生率, リスク因子, 葉酸サプリメントの摂取, 行政への要望. 日周産期新生児会誌 57:8-18, 2021

 

P.203 掲載の参考文献

3) Adzick NS, Thom EA, Spong CY et al;MOMS Investigators:A randomized trial of prenatal versus postnatal repair of myelomeningocele. N Engl J Med 364:993-1004, 2011

 

P.204 掲載の参考文献

4) Elbabaa SK, Gildehaus AM, Pierson MJ et al:First 60 fetal in-utero myelomeningocele repairs at Saint Louis Fetal Care Institute in the post-MOMS trial era:hydrocephalus treatment outcomes (endoscopic third ventriculostomy versus ventriculoperitoneal shunt). Childs Nerv Syst 33:1157-1168, 2017

 

5) Omar AT, Espiritu AI, Spears J:Endoscopic third ventriculostomy with or without choroid plexus coagulation for myelomeningocele-associated hydrocephalus:systematic review and meta-analysis. J Neurosurg Pediatr 29:435-443, 2022

 

6) Albalkhi I, Garatli S, Helal B et al:Morbidity and etiology-based success rate of combined endoscopic ventriculostomy and choroid plexus cauterization:a systematic review and meta-analysis of 1918 infants. Neurosurg Rev 46:180, 2023

 

7) Warf BC, Weber DS, Day EL et al:Endoscopic third ventriculostomy with choroid plexus cauterization:predictors of long-term success and comparison with shunt placement for primary treatment of infant hydrocephalus. J Neurosurg Pediatr 32:201-213, 2023

 

8) Tulipan N, Wellons JC 3rd, Thom EA et al:Prenatal surgery for myelomeningocele and the need for cerebrospinal fluid shunt placement. J Neurosurg Pediatr 16:613-620, 2015

 

9) Agrawal S, Al-Refai A, Abbasi N et al:Correlation of fetal ventricular size and need for postnatal cerebrospinal fluid diversion surgery in open spina bifida. Ultrasound Obstet Gynecol 59:799-803, 2022

 

10) Donepudi R, Brock C, Schulte S et al:Trend in ventricle size during pregnancy and its use for prediction of ventriculoperitoneal shunt in fetal open neural tube defect. Ultrasound Obstet Gynecol 56:678-683, 2020

 

P.205 掲載の参考文献

11) Mitts MD, Whitehead W, Corroenne R et al:Prenatal surgery in fetal myelomeningocele with severe ventriculomegaly. Ultrasound Obstet Gynecol, 2024. doi:10.1002/uog.27585

 

12) Lapa DA, Chmait RH, Gielchinsky Y et al:Percutaneous fetoscopic spina bifida repair:effect on ambulation and need for postnatal cerebrospinal fluid diversion and bladder catheterization. Ultrasound Obstet Gynecol 58:582-589, 2021

 

13) Trigo L, Chmait RH, Llanes A et al:Revisiting MOMS criteria for prenatal repair of spina bifida:upper gestational-age limit should be raised and assessment of prenatal motor function rather than anatomical level improves prediction of postnatal function. Ultrasound Obstet Gynecol 63:53-59, 2024

 

14) Houtrow AJ, Thom EA, Fletcher JM et al:Prenatal repair of myelomeningocele and school-age functional outcomes. Pediatrics 145:e20191544, 2020

 

15) Sanz Cortes M, Corroenne R, Pyarali M et al:Ambulation after in-utero fetoscopic and open spina bifida repair:predictors for ambulation at 30 months. Ultrasound Obstet Gynecol, 2024. doi:10.1002/uog.27589

 

P.206 掲載の参考文献

16) Brock JW 3rd, Carr MC, Adzick NS et al:Bladder function after fetal surgery for myelomeningocele. Pediatrics 136:906-913, 2015

 

17) Brock JW 3rd, Thomas JC, Baskin LS et al:Effect of prenatal repair of myelomeningocele on urological outcomes at school age. J Urol 202:812, 2019

 

18) Clayton DB, Thomas JC, Brock JW 3rd:Fetal repair of myelomeningocele:current status and urologic implications. J Pediatr Urol 16:3-9, 2020

 

19) Feng S, Yang Y, Yu Z et al:Folic acid supplementation rescues bladder injury in fetal rats with myelomeningocele. Birth Defects Res 115:1685-1692, 2023

 

20) Sasaoka AKS, Moron AF, Araujo Junior E et al:Ultrasound evaluation of uterine scar thickness after open fetal surgery for myelomeningocele. Childs Nerv Syst 39:655-661, 2023

 

21) McLone DG, Knepper PA:The cause of Chiari II malformation:a unified theory. Pediatr Neurosci 15:1-12, 1989

 

22) Heffez DS, Aryanpur J, Hutchins GM et al:The paralysis associated with myelomeningocele:clinical and experimental data implicating a preventable spinal cord injury. Neurosurgery 26:987-992, 1990

 

P.207 掲載の参考文献

23) Espinoza J, Shamshirsaz AA, Sanz Cortes M et al:Two-port, exteriorized uterus, fetoscopic meningomyelocele closure has fewer adverse neonatal outcomes than open hysterotomy closure. Am J Obstet Gynecol 225:327. e1-327. e9, 2021

 

24) Joyeux L, van der Merwe J, Aertsen M et al:Neuroprotection is improved by watertightness of fetal spina bifida repair in the sheep model. Ultrasound Obstet Gynecol 61:81-92, 2023

 

25) Coelho G, Trigo L, Faig F et al:The potential applications of augmented reality in fetoscopic surgery for antenatal treatment of myelomeningocele. World Neurosurg 159:27-32, 2022

 

26) Joyeux L, De Bie F, Danzer E et al:Learning curves of open and endoscopic fetal spina bifida closure:systematic review and meta-analysis. Ultrasound Obstet Gynecol 55:730-739, 2020

 

P.208 掲載の参考文献

27) Nonaka M, Komori Y, Isozaki H et al:Current status and challenges of neurosurgical procedures for patients with myelomeningocele in real-world Japan. Childs Nerv Syst 39:3137-3145, 2023

 

28) 香川尚己, 渡邊美穂, 遠藤誠之:脊髄髄膜瘤胎児手術の治療. 小児外科 55:56-62, 2023

 

29) MRC Vitamin Study Research Group:Prevention of neural tube defects:results of the Medical Research Council Vitamin Study. Lancet 338:131-137, 1991

 

30) Caceres A, Jimenez-Chaverri AL, Alpizar-Quiros PA et al:Pre and postnatal care characteristics and management features of children born with myelomeningocele in the post-folate fortification era of staple foods in Costa Rica (2004-2022). Childs Nerv Syst 39:1755-1764, 2023

 

31) Mai CT, Evans J, Alverson CJ et al:Changes in spina bifida lesion level after folic acid fortification in the US. J Pediatr 249:59-66, 2022

 

P.209 掲載の参考文献

32) Zanon N, Dos Santos Silva RP, Varjao Vieira E et al:Spina bifida folate fortification in Brazil, update 2022:a cross-sectional study. Childs Nerv Syst 39:1765-1771, 2023

 

P.210 掲載の参考文献

1) Morota N, Sakamoto H:Surgery for spina bifida occulta:spinal lipoma and tethered spinal cord. Childs Nerv Syst 39:2847-2864, 2023

 

P.211 掲載の参考文献

2) Perera D, Craven CL, Thompson D:Lumbosacral lipoma in childhood, how strong is the evidence base? A systematic review. Childs Nerv Syst 40:715-728, 2024

 

3) Casado-Ruiz J, Ros B, Iglesias S et al:Spinal cord lipomas:lessons learned in the era of total resection. Childs Nerv Syst 40:1121-1128, 2024

 

P.212 掲載の参考文献

4) Saeed F, Tyagi A:Transition from partial to near-total/radical resection of spinal cord lipomas. Childs Nerv Syst 39:1595-1602, 2023

 

5) Lim JX, Fong E, Goh C et al:Complex lumbosacral spinal cord lipomas:a longitudinal study on outcomes from a Singapore children's hospital. J Clin Neurosci 121:119-128, 2024

 

P.213 掲載の参考文献

6) Idriceanu T, Beuriat PA, Di Rocco F et al:Recurrent tethering in conus lipomas:a late complication not to be ignored. World Neurosurg 168:e12-e18, 2022

 

7) Moreno Gomez LM, Garcia-Perez D, Gonzalez-Leon PJ et al:Pathogenesis of spinal intramedullary lipomas:two case reports. J Med Case Rep 17:317, 2023

 

P.214 掲載の参考文献

8) Sagenly M, Karnoub MA, Vinchon M:Non-dysraphic intramedullary spinal cord lipoma of the child:report of 3 cases. Neurochirurgie 69:101473, 2023

 

9) Roohollahi F, Sharifi V, Abousaeidi SR et al:Adult nondysraphic cervicomedullary intramedullary lipoma:a case report and literature review. Clin Case Rep 11:e7239, 2023

 

10) Oketani H, Harimaya K, Ono T et al:A presenile patient with filar lipoma who developed tethered spinal cord syndrome triggered by lumbar canal stenosis. NMC Case Rep J 10:109-113, 2023

 

P.215 掲載の参考文献

11) Pahari S, Thapa S, Bhattarai B et al:Lipomeningocele with tethered cord syndrome in an adult:a case report. J Nepal Med Assoc 61:620-622, 2023

 

12) Ishisaka E, Tahara S, Tsukiyama A et al:Endoscopic spinal cord untethering using a 1 cm skin incision technique in pediatrics:a technical case report. BMC Pediatr 23:604, 2023

 

13) Ogawa Y, Hayashi H, Sasaki R et al:Motor-evoked potential monitoring from urinary sphincter muscle during pediatric untethering surgery:a case series. Childs Nerv Syst 39:2147-2153, 2023

 

14) Morizawa Y, Satoh H, Arai M et al:Urodynamics findings pre- and postuntethering surgery in children with filum lipoma:a single-institution experience. Int J Urol 29:884-889, 2022

 

P.216 掲載の参考文献

15) Lim JX, Low SY, Ng LP et al:Prevention and treatment of CSF leaks in congenital complex spinal lipomas. Acta Neurochir (Wien) 164:1157-1160, 2022

 

16) Gao D, Bao N, Yang B et al:Preventive surgery for asymptomatic spinal lipomas in children. Turk Neurosurg 34:1-5, 2024

 

P.217 掲載の参考文献

1) Kim JW, Kim KH, Phi JH et al:Neurocognitive outcomes and associated clinical factors 5 years after surgery in children with craniosynostosis. J Neurosurg Pediatr 33:602-609, 2024

 

P.218 掲載の参考文献

2) Aksogan Y, Kuzucu P, Soysal Acar AS et al:Evaluation of neurocognitive and social developments after craniosynostosis surgery. Childs Nerv Syst 40:1489-1499, 2024

 

3) Junn AH, Long AS, Hauc SC et al:Long-term neurocognitive outcomes in 204 single-suture craniosynostosis patients. Childs Nerv Syst 39:1921-1928, 2023

 

4) Long AS, Hauc SC, Almeida MN et al:"Morphologic severity and age at surgery are associated with school age neurocognitive outcomes in metopic craniosynostosis". Plast Reconstr Surg, 2023. doi:10.1097/PRS.0000000000010999

 

5) Magge SN, Fotouhi AR, Allhusen V et al:Cognitive outcomes of children with sagittal craniosynostosis treated with either endoscopic or open calvarial vault surgery. JAMA Netw Open 7:e248762, 2024

 

P.219 掲載の参考文献

6) Kurniawan M, van de Beeten SDC, Raat H et al:Health-related quality of life in children and adolescents with sagittal synostosis. J Craniofac Surg 34:2284-2287, 2023

 

7) Hevia-Rodriguez P, Romero-Lopez C, Martin-Fernandez J et al:Endoscopy-assisted craniosynostosis surgery without postoperative helmet molding therapy. World Neurosurg 183:79-85, 2024

 

8) Lutz K, Rohrig A, Al-Hourani J et al:Long-term results of minimally invasive strip craniectomy without helmet therapy for scaphocephaly - a single-centre experience. Neurosurg Rev 47:164, 2024

 

9) Fotouhi AR, Patel KB, Skolnick GB et al:School-age anthropometric and patient-reported outcomes after open or endoscopic repair of sagittal craniosynostosis. J Neurosurg Pediatr 32:455-463, 2023

 

P.220 掲載の参考文献

10) Uno K, Sakamoto Y, Miwa T:Is postoperative helmet molding therapy necessary for craniectomy for sagittal suture synostosis? J Craniofac Surg 35:111-113, 2024

 

11) Cross C, Delye H, Khonsari RH et al:A preliminary analysis of replicating the biomechanics of helmet therapy for sagittal craniosynostosis. Childs Nerv Syst 39:989-996, 2023

 

12) Yousefi O, Taheri R, Sabahi M et al:Outcomes of the early endoscopic-assisted suturectomy for treatment of multisuture craniosynostosis. Neurosurg Rev 46:289, 2023

 

13) Labuschagne J, Mutyaba D, Ouma J et al:Flexible endoscope-assisted suture release and barrel stave osteotomy for the correction of sagittal synostosis. J Neurosurg Pediatr 31:71-77, 2023

 

P.221 掲載の参考文献

14) Berton Q, Arrighi M, Barthelemy I et al:Reossification of bone defects after surgical correction of nonsyndromic craniosynostosis:a review and an original study. Neurosurgery, 2024. doi:10.1227/neu.0000000000002854

 

15) Wagner CS, Pontell ME, Shakir S et al:Utilization of carbonated calcium phosphate cement for contouring cranioplasty in patients with syndromic craniosynostosis. Childs Nerv Syst 39:2155-2160, 2023

 

16) Chocron Y, Alabdulkarim A, Gilardino MS:Patient-specific implants and fat grafting for contour deformities post craniosynostosis reconstruction:a therapeutic approach. J Craniofac Surg 34:959-963, 2023

 

17) Gaillard L;ERN CRANIO-Craniosynostosis Workgroup:A photo score for aesthetic outcome in sagittal synostosis:an ERN CRANIO collaboration. J Craniofac Surg 34:2279-2283, 2023

 

18) Leclair NK, Chern J, Ahn ES et al:Clinical metrics and tools for provider assessment and tracking of trigonocephaly. J Neurosurg Pediatr 32:82-90, 2023

 

19) Messerer M, Cottier R, Vandenbulcke A et al:Aesthetic results in children with single suture craniosynostosis:proposal for a modified Whitaker classification. Childs Nerv Syst 39:221-228, 2023

 

P.222 掲載の参考文献

1) Dirik MA, Sanlidag B:Intracranial cysts:incidental or neurodevelopmental? Childs Nerv Syst 39:775-780, 2023

 

P.223 掲載の参考文献

2) Ramachandran T, Valayatham V, Ganesan D:Postnatal posterior fossa arachnoid cyst:a developmental etiology to be considered. Asian J Neurosurg 17:676-679, 2022

 

P.224 掲載の参考文献

3) Zhao H, Cao L, Zhao Y et al:Clinical value of classification in the treatment of children with suprasellar arachnoid cysts. Childs Nerv Syst 39:767-773, 2023

 

P.226 掲載の参考文献

4) Massimi L, Bianchi F, Benato A et al:Ruptured Sylvian arachnoid cysts:an update on a real problem. Childs Nerv Syst 39:93-119, 2023

 

P.231 掲載の参考文献

5) AlMousa SS:A 3-year-old girl with brain imaging findings suggesting arachnoid cyst, and biopsy diagnosis of extra-axial multi-cystic pilocytic astrocytoma. Am J Case Rep 25:e941990, 2024

 

6) Watson I, Patrick J, McDonald PJ et al:Acetazolamide to treat symptomatic ruptured arachnoid cysts:illustrative cases. J Neurosurg Case Lessons 3:CASE21462, 2022

 

7) Beltagy MAE, Enayet AER:Surgical indications in pediatric arachnoid cysts. Childs Nerv Syst 39:87-92, 2023

 

8) Sahap SK, Unal S, Fitoz S:The unique features of middle cranial fossa and Sylvian fissure arachnoid cysts in children:MRI evaluation. Childs Nerv Syst 39:79-85, 2023

 

9) Guler TM, Sahinoglu M, Sen HE et al:Effectiveness of multiple endoscopic fenestrations for the treatment of Sylvian fissure arachnoid cysts:a multicenter study. Childs Nerv Syst 39:121-125, 2023

 

10) Tomita T, Kwasnicki AM, McGuire LS et al:Temporal sylvian fissure arachnoid cyst in children:treatment outcome following microsurgical cyst fenestration with special emphasis on cyst reduction and subdural collection. Childs Nerv Syst 39:127-139, 2023

 

11) Drozdz A, Wojciechowski T, Ciszek B et al:Large intradiploic arachnoid cyst of the skull in child - a case report and new terminology proposition. Childs Nerv Syst 40:1271-1276, 2024

 

12) Chanclud J, Valence S, Perre SV et al:Prenatal diagnosis of vermian cyst:a new type of posterior fossa cyst. Pediatr Radiol 53:461-469, 2023

 

13) Kadri H, Dughly M, Agha MS et al:Giant supra and retrosellar glioependymal cyst presenting with only precocious puberty. Clinical study and review of the literature. Int J Surg Case Rep 116:109360, 2024

 

14) Yamila BM, Pablo NJ, Romina A et al:Surgical treatment of a patient with a giant choroidal fissure cyst:a case report. Childs Nerv Syst 39:1097-1100, 2023

 

15) He Y, Zhang S:An unexpected case report of epidermoid cyst at the oculomotor nerve:mimicking a common cyst on MRI. Front Endocrinol (Lausanne) 14:1153263, 2023

 

16) Gotecha S, Chugh A, Punia P et al:Epidermoid cyst of the brainstem in 3-year-old child:a rare case report. Indian J Otolaryngol Head Neck Surg 76:1224-1228, 2024

 

17) Laverde-Reyes MF, Marquez JC, Nasner D et al:Intracranial progression of the epidermoid cyst to a white epidermoid cyst in a pediatric patient:a case report. J Med Case Rep 17:495, 2023

 

18) Stavarache I, Parazzini C, Doneda C et al:Spontaneous regression of an epidermoid cyst in a pediatric patient - case report and review of the literature. Childs Nerv Syst 40:1961-1964, 2024

 

VI章 脊髄・脊椎・末梢神経

P.235 掲載の参考文献

1) Chiba K, Matsuyama Y, Seo T et al:Condoliase for the treatment of lumbar disc herniation:a randomized controlled trial. Spine (Phila Pa 1976) 43:E869-E876, 2018

 

2) Matsuyama Y, Seo T, Chiba K:Condoliase chemonucleolysis for lumbar disc herniation:a post-hoc follow-up study of patients in previous clinical trials. J Orthop Sci 28:724-732, 2023

 

3) Banno T, Hasegawa T, Yamato Y et al:Condoliase therapy for lumbar disc herniation -2 year clinical outcome. J Orthop Sci 29:64-70, 2024

 

P.236 掲載の参考文献

4) Ohtonari T, Torii R, Noguchi S et al:Short-term clinical and radiographic outcomes of chemonucleolysis with condoliase for painful lumbar disc herniation and analysis regarding intradiscal injection area. Neurosurg Rev 46:59, 2023

 

5) Huang Z, Xu B, Liu Y et al:The efficacy and safety of condoliase for lumbar disc herniation:a systematic review and meta-analysis. Front Pharmacol 14:1151998, 2023

 

6) Banno T, Hasegawa T, Yamato Y et al:Psychological factors can affect the clinical outcome of chemonucleolysis with condoliase in patients with lumbar disk herniation. Spine Surg Relat Res 8:195-202, 2024

 

P.237 掲載の参考文献

7) Banno T, Hasegawa T, Yamato Y et al:Efficacy of chemonucleolysis with condoliase in patients aged under 20 years. Spine Surg Relat Res, 2024. doi:10.22603/ssrr.2023-0289

 

8) Kagami Y, Nakashima H, Segi N et al:Clinical outcomes of condoliase injection therapy for lateral lumbar disc herniation. Spine Surg Relat Res 7:363-370, 2023

 

P.238 掲載の参考文献

9) Fukui H, Kamei N, Fujiwara Y et al:Intradiscal condoliase injection therapy for recurrent lumbar disc herniation:case series and literature review. Medicina (Kaunas) 59:1561, 2023

 

10) Inoue M, Sainoh T, Kojima A et al:Efficacy and safety of condoliase disc administration as a new treatment for lumbar disc herniation. Spine Surg Relat Res 6:31-37, 2022

 

P.239 掲載の参考文献

11) Takaki S, Miyama H, Iwasaki M:Cost-effectiveness analysis of intradiscal condoliase injection vs. surgical or conservative treatment for lumbar disc herniation. J Med Econ 26:233-242, 2023

 

12) Kobayashi K, Sato K, Ando T et al:MRI characteristics of disc degeneration after condoliase injection in young patients:a consecutive case series. J Orthop Sci 29:494-501, 2024

 

P.240 掲載の参考文献

13) Ju DG, Kanim LE, Bae HW:Intervertebral disc repair:current concepts. Global Spine J 10 (2 Suppl):130S-136S, 2020

 

14) 木下英幸, 鴨田博人, 折田純久他:脊椎領域におけるPRPを用いた組織再生. 臨床整形外科 54:92-99, 2019

 

15) Kawabata S, Nagai S, Ito K et al:Intradiscal administration of autologous platelet-rich plasma in patients with Modic type 1 associated low back pain:a prospective pilot study. JOR Spine 7:e1320, 2024

 

16) Zhang L, Zhang C, Song D et al:Combination of percutaneous endoscopic lumbar discectomy and platelet-rich plasma hydrogel injection for the treatment of lumbar disc herniation. J Orthop Surg Res 18:609, 2023

 

P.241 掲載の参考文献

17) Hasegawa T, Akeda K, Yamada J et al:Regenerative effects of platelet-rich plasma releasate injection in rabbit discs degenerated by intradiscal injection of condoliase. Arthritis Res Ther 25:216, 2023

 

P.243 掲載の参考文献

1) Abel F, Avrumova F, Goldman SN et al:Robotic-navigated assistance in spine surgery. Bone Joint J 105-B:543-550, 2023

 

2) Li C, Wang Z, Li D et al:Safety and accuracy of cannulated pedicle screw placement in scoliosis surgery:a comparison of robotic-navigation, O-arm-based navigation, and freehand techniques. Eur Spine J 32:3094-3104, 2023

 

3) Tovar M, Dowlati E, Zhao DY et al:Robot-assisted and augmented reality-assisted spinal instrumentation:a systematic review and meta-analysis of screw accuracy and outcomes over the last decade. J Neurosurg Spine 37:299-314, 2022

 

4) Toossi N, Vardiman AB, Benech CA et al:Factors affecting the accuracy of pedicle screw placement in robot-assisted surgery:a multicenter study. Spine (Phila Pa 1976) 47:1613-1619, 2022

 

5) 川口善治, 牧野絋士, 安田剛敏他:ロボット支援脊椎手術:開発の歴史, 現状, 導入初期の使用経験, 将来展望. J Spine Res 14:59-64, 2023

 

6) Akazawa T, Torii Y, Ueno J et al:Accuracy of computer-assisted pedicle screw placement for adolescent idiopathic scoliosis:a comparison between robotics and navigation. Eur Spine J 32:651-658, 2023

 

P.244 掲載の参考文献

7) Lee NJ, Zuckerman SL, Buchanan IA et al:Is there a difference in screw accuracy, robot time per screw, robot abandonment, and radiation exposure between the Mazor X and the Renaissance? A propensity-matched analysis of 1179 robot-assisted screws. Global Spine J 13:1286-1293, 2023

 

8) Wei FL, Gao QY, Heng W et al:Association of robot-assisted techniques with the accuracy rates of pedicle screw placement:a network pooling analysis. eClinicalMedicine 48:101421, 2022

 

9) Patel NA, Kuo CC, Pennington Z et al:Robot-assisted percutaneous pedicle screw placement accuracy compared with alternative guidance in lateral single-position surgery:a systematic review and metaanalysis. J Neurosurg Spine 39:443-451, 2023

 

10) Brown NJ, Pennington Z, Kuo CC et al:Retrospective single-surgeon study of prone versus lateral robotic pedicle screw placement:a CT-based assessment of accuracy. J Neurosurg Spine 39:490-497, 2023

 

11) Fayed I, Tai A, Triano MJ et al:Lateral versus prone robot-assisted percutaneous pedicle screw placement:a CT-based comparative assessment of accuracy. J Neurosurg Spine 37:112-120, 2022

 

P.245 掲載の参考文献

12) Shahi P, Subramanian T, Araghi K et al:Comparison of robotics and navigation for clinical outcomes after minimally invasive lumbar fusion. Spine (Phila Pa 1976) 48:1342-1347, 2023

 

13) Liounakos JI, Khan A, Eliahu K et al:Ninety-day complication, revision, and readmission rates for current-generation robot-assisted thoracolumbar spinal fusion surgery:results of a multicenter case series. J Neurosurg Spine 36:841-848, 2022

 

14) Shahi P, Subramanian T, Maayan O et al:Surgeon experience influences robotics learning curve for minimally invasive lumbar fusion:a cumulative sum analysis. Spine (Phila Pa 1976) 48:1517-1525, 2023

 

15) Feng F, Chen X, Liu Z et al:Learning curve of junior surgeons in robot-assisted pedicle screw placement:a comparative cohort study. Eur Spine J 33:314-323, 2024

 

16) 谷陽一, 田中貴大, 川島康輝他:脊椎ロボット支援下のPPS刺入精度-脊椎手術経験の多寡は影響するか?-. J Spine Res 14:1109-1116, 2023

 

P.246 掲載の参考文献

17) Beyer RS, Nguyen A, Brown NJ et al:Spinal robotics in cervical spine surgery:a systematic review with key concepts and technical considerations. J Neurosurg Spine 38:66-74, 2023

 

18) Zhou LP, Zhang ZG, Li D et al:Robotics in cervical spine surgery:feasibility and safety of posterior screw placement. Neurospine 20:329-339, 2023